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ABSTRACT

In utero exposure to second-hand smoke (SHS) has modulatory effects on adult lung
responses to various irritants. To further elucidate diverse responses with different inhaled
irritants and to understand how long the effects persist, we have focused on two
environmentally-relevant and asthma-associated irritants--SHS and ovalbumin (OVA)--for adult
mice that had been exposed in utero to SHS.
We hypothesized that in utero SHS exposure aggravates lung responses to various
inhaled irritants, including SHS and OVA, in adult mice beyond the age of 15 weeks; and that
the responses will likely exhibit a sex bias.
Pregnant BALB/c mice were exposed (days 6-19 of pregnancy) to SHS (10 mg/m3) or
HEPA-filtered air (AIR). The lung responses of 15-week-old male offspring were examined
after daily exposure from 11-15 weeks of age to either SHS or AIR. Another set of lung
responses were assessed on 23-week-old mice, both females and males, after OVA sensitization
and challenge from 19-23 weeks of age. The assessments focused on pulmonary function,
bronchoalveolar lavage fluid (BALF), histopathology, and lung transcriptome screening
(mRNAs and miRNAs).
In utero SHS exposure significantly aggravates lung responses in synergy with recurring
SHS to 15-week-old male mice, shown by increased airway hyper-responsiveness (AHR) and
BALF pro-inflammatory cytokines. Additional morphometric analysis and transcriptome
screening indicated that in utero exposure resulted in enlarged air spaces and arteries in adult
mice regardless of adult irritants. In the case of recurring (adult) SHS exposure, pro-fibrotic
genes were activated. This also was evident by increased collagen deposition in the lungs. On
the other hand, in utero SHS exposure also aggravated lung responses to OVA in 23-week-old
ix

mice, as indicated by further increased lung inflammation, AHR, BALF Th2 cytokines, and proasthmatic gene expression changes, with the majority of responses being more pronounced in
males than in females. Furthermore, the additional miRNA expression screening identified
overexpressed miRNAs that are oncogenic; 16 tumor suppressor genes, as targets of these
miRNAs, were found to be down-regulated.
In conclusion, in utero SHS exposure elicits deleterious effects on adult mice challenged
with inhaled irritants, and may promote and predispose affected individuals to certain
respiratory diseases.

x

CHAPTER 1.
LITERATURE REVIEW
1.1 Short-term and Long-term Effects of Air Pollutants
Highly toxic air pollutants at relatively high doses often trigger acute lung responses
and/or drastically exacerbate respiratory diseases in humans shortly after the initial exposure,
and may even result in premature death. In the winter of 1952, the Great Smog in London killed
4,000 people and made 100,000 more ill within a week because of the smog's effects on the
human respiratory system (Bell and Davis 2001; U.K. Ministry of Health 1954). In the case of
Yokkaichi Asthma (1960-1972), an environmental disaster in Japan, the combustion products of
petroleum and crude oil containing sulfur heavily polluted ambient air and induced severe cases
of COPD, chronic bronchitis, pulmonary emphysema, and bronchial asthma among the local
inhabitants, especially for those over the age 50 (Guo et al. 2008; Yoshida 1984).
In other cases, where environmental exposures only occurred at relatively low doses,
immediately noticeable changes were not elicited; instead, such exposures have the ability to
potentiate future lung responses and/or to accelerate the progression of chronic respiratory
diseases, especially after a prolonged period of exposure (MacNee 2009). Therefore, a lag time
exists between initial exposure and disease incidence or mortality. In the case of lung cancer, as
shown in Figure 1-1, the increased numbers of premature deaths in the past hundred years was
preceded by a dramatic elevation in cigarette consumption with a time lag of ~20 years.
A similar approximate 20-year lag may be expected between years of smoke exposure
and the onset of other respiratory diseases, e.g., COPD, which is more common among
people >65 years old than in younger people (Centers for Disease Control and Prevention 2011).
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Asthma, another serious respiratory disease, is frequently diagnosed in children, especially
below the age of 18 (Centers for Disease Control and Prevention 2011)

Figure 1–1. Correlation between smoking and lung cancer in US males, showing a 20-year time
lag between increased smoking rates and increased incidence of lung cancer (NIH.gov).
The incidence and prevalence of asthma have been increasing dramatically in the past
fifty years both in the United States (Mannino et al. 2002) and world-wide (Pearce et al. 2000).
The global burden of asthma has been estimated to be as high as 300 million people (Masoli et
al. 2003). On the other hand, in the United States, cigarette consumption has being decreasing
(Figure 1-2) and air quality has been improving (Table 1-1) over the past 30 years, according to
the official data.
If environmental stressors play a role in the increased asthma incidence, could there also
be a considerable time-lag between exposure to the stressor and clinical appearance of the
disease? If we assume there was also a many-years lag, this could put the time frame of initial
impact even before the asthma-prone children were born, i.e., within the in utero environment.
Although cigarette consumption in the US has decreased in the past 30 years, 25% of adults
2

continue to smoke on a regular basis (Matthews 2001), and 10.7% of pregnant females smoke
during last 3 months of pregnancy (Centers for Disease Control and Prevention 2010). This
suggested that the in utero exposure to cigarette smoke could be a contributing factor for
increased asthma prevalence in children.
Table 1–1. Decreases in concentrations of common pollutants indicated that air quality has
improved nationally since 1980 (EPA.gov).
Percentage change (%)
Carbon Monoxide (CO)
Ozone (O3) (8-hr)
Lead (Pb)
Nitrogen Dioxide (NO2) (annual)
Nitrogen Dioxide (NO2) (1-hour)
PM10 (24-hr)
PM2.5 (annual)
PM2.5 (24-hr)
Sulfur Dioxide (SO2) (1-hour)

1980vs2012
-83
-25
-91
-56
-60
-------78

1990vs2012
-75
-14
-87
-50
-46
-39
-----72

2000vs2012
-57
-9
-52
-38
-29
-27
-33
-37
-54

Figure 1–2. The trend of cigarette consumption in the U.S. plateaued between 1950s and 1980s
(CDC.gov). Adult per capita cigarette consumption and major smoking and health events in the
3

United States from 1900 to 1999. Reprinted from The US Surgeon General's Report for the Year
2000.
1.2 Early Onset of Adult Respiratory Diseases
Early development of the mouse lung is a complex, multistage process which begins on
E9 (embryonic day 9; week 3-4 in humans), when the lung buds appear and branching starts. As
illustrated in Figure 1-3, other than the final stage, alveolar maturation, which takes place in the
early postnatal environment, the early stages of lung development, including pseudoglandular,
canalicular and saccular stages, occur in the in utero environment.

Figure 1–3. Lung development stages in humans. Equivalent time periods in mouse: embryonic, E
9-12; pseudoglandular, E 12-15; Canalicular, E 15-17; Saccular, E 17-Birth; Alveolar, Birth-PN
20. E, embryonic day. PN, postnatal day. The figure was adapted from (Kajekar et al. 2007).
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In the pseudoglandular stage, major conducting airways are formed and airway
branching reaches the level of the acinus, which is a collective term for the respiratory zone of
the lung. The canalicular stage that follows is characterized by completion of the airway
branching pattern, which marks the early stages of the future gas-exchange region. The saccular
stage is characterized by coordinated growth of the pulmonary parenchyma and maturation of
the neural network, while the alveoli, the gas-exchange units of the adult lung, are not yet fully
developed. The final stage, alveolar maturation, takes places in the postnatal environment.
During this final stage, gas exchange area, nerves and capillaries are fully expanded and matured.
Epidemiological studies have associated exposure to in utero stressors with intrauterine
growth restriction and increased risk of respiratory problems and reduced lung function in
infants, children and adults. In humans, the lungs are constantly undergoing progressive and
irreversible increases in alveolar diameter, together with degradation of pulmonary structural
proteins, leading to a reduction in the surface area available for gas exchange (Cotes et al. 1997).
These changes predispose small airways to narrowing during expiration. Therefore, lung health
and lung function during later life are dependent on the architecture of lung parenchyma that is
laid down in the critical development period in early life (Figure 1-4).
In animal models, restricted growth in utero has been linked to reduction of internal
surface area relative to lung volumes (Harding et al. 2000) and impaired growth of bronchial
walls, which may have implications for airway compliance in later life (Wignarajah et al. 2002).
Not only is the in utero environment crucial for fetal lung development, uterine life is
also critical for epigenetic programming, when environmental factors have the most potential to
modulate subsequent lung responses to inhaled irritants and contribute to the susceptibility of
adult diseases and disorders (Durham et al. 2010; Ho 2010).
5

Figure 1–4. Early origins of adult lung disease. The blue line indicates healthy people (normally
reaching maximum lung function at 22 years of age); red line represents people with suboptimal
lung function. The dashed red line on the left represents those people with hindered lung
development at an early age; the dashed red & blue lines on the right indicate people experiencing
accelerated decline of lung function. The figure was adapted from (Stocks et al. 2013).
The programming effects in utero are believed to be primarily epigenetic, because of the
stable nature of the genome (Jirtle and Skinner 2007; Szyf 2007). Since the majority of
environmental factors and toxicants do not alter DNA sequence or promote genetic mutations,
the epigenetic modifications are defined as the molecular factors and processes around DNA
that regulate genome activity independent of DNA sequence and that are mitotically stable; as
shown in Figure 1-5, these modification includes small non-coding RNAs, DNA methylations
and histone modifications (Skinner and Guerrero-Bosagna 2009). These changes have the
potential to explain the abnormal adult phenotypes or diseases that originated from early-life
exposures (Hanson and Gluckman 2008).

6

Figure 1–5. The multidimentional nature of epigenetics. DNA: hyper/hypo-methylation; RNA:
regulatory/edited RNA; PROTEIN: histone modification, chromatin remodeling and prion. This
figure was adapted from (Chahwan et al. 2011).
DNA methylation is an adaptable epigenetic mechanism that, in mammals, modifies
genome function through the addition of methyl groups to cytosine. The methylation marks are
largely established early in life (Feinberg 2007; Gluckman et al. 2008) and may ensure stable
regulation that mediates persistent changes in biological and behavioral phenotypes over the
lifespan (Miller and Ho 2008; Weaver et al. 2002; Wright 2010). DNA methylation is a crucial
epigenetic modification of the genome that is involved in regulating many cellular processes,
such as embryonic development, transcription, X chromosome inactivation and genomic
imprinting.
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miRNAs which are short double stranded RNA that mediate the post-transcriptional
regulation of gene expression, are among the most characterized non-coding RNAs,.
Bioinformatics studies suggest that up to a third of all known genes may be regulated by miRNA
through RNA interference (Williams et al. 2007). Previous studies have implicated active roles
for miRNAs in the course of development (Williams et al. 2006), aging processes (Boehm and
Slack 2005) and the induction of diseases, including cancer (McManus 2003).
Histone proteins play a key role in chromosome assembly in the formation of
nucleosomes. Amino-terminal tails of core histones are susceptible to a variety of enzymecatalyzed posttranslational modifications, including acetylation, methylation, phosphorylation,
etc. These modifications have long-term effects on chromatin assembly and regulate gene
expression. So far, the most well understood histone modification is acetylation of H3 and H4.
Generally, increased acetylation is associated with increased transcriptional activity and vice
versa. But effects of other modifications are less clear. Furthermore, histone modification may
interact with DNA methylation, participating in chromatin remodeling (Henckel et al. 2009;
Tamaru and Selker 2001).
Emerging evidence has suggested that epigenetics is involved in the ability of
environmental experiences to regulate the genome and to develop stable alterations in phenotype
(Jirtle and Skinner 2007). During immune system maturation, an important determinant for
developing allergic asthma, T-cell differentiation is under epigenetic regulation (Janson et al.
2009; Fields et al. 2002) and directly influenced by various maternal stimuli, including
microbial exposure (Djuardi et al. 2011; Inman et al. 2010), dietary methyl donors (Miller 2008;
Hollingsworth et al. 2008) and cigarette smoke (Breton et al. 2009; Murphy et al. 2012).
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1.3 In Utero Smoke Exposure Studies and the Current Experimental Design
Second-hand smoke (SHS), previously called environmental tobacco smoke, is
comprised of approximately 85-90% sidestream smoke and 10-15% exhaled mainstream smoke.
Sidestream smoke arises from the burning end of the cigarette. This smoke, which does not pass
through the cigarette filter, is more toxic to human lungs than mainstream smoke (Schick and
Glantz 2005), and its toxicity is further increased with aging (Schick and Glantz 2006). By
convention, sidestream smoke routinely has been generated as a surrogate for SHS.
It has been established that maternal exposure to cigarette smoke can affect fetal lung
development (Blacquiere et al. 2009), contributing to an increased risk of subsequent asthma
and respiratory disease (Hylkema and Blacquière 2009).
SHS has been examined by many researchers and has been associated with exacerbation
of adult asthma and allergy symptoms (Jaakkola et al. 2003; Lajunen et al. 2013). Studies have
evaluated the role of SHS in initiation of allergic asthma in the perinatal period (DiFranza et al.
2004; Hong et al. 2003; Jaakkola et al. 2006). The synergistic effects of in utero SHS exposure
and various adult irritants, including house dust mite (Raherison et al. 2008) and A. fumigatus
(Singh et al. 2011), have been revealed by different researchers.
From the vast majority of our previously conducted experiments, in utero SHS exposure
of mice, by itself, does not particularly elicit lung responses different from those of the control
group mice. However, a second challenge of adult mouse lungs to inhaled irritants, particularly
ovalbumin (OVA), induced significantly aggravated effects in 15-week old mice that had been
exposed in utero to SHS (Penn et al. 2007; Rouse et al. 2007).
There also are human studies that identified epigenetic changes due to in utero smoke
exposures. Alterations on global and gene-specific DNA methylation were found in the buccal
9

cells of children exposed in utero to SHS (Breton et al. 2009). Similarly, there were
differentially methylated CpG islands, which were mapped to key genes, including AHRR and
CYP1A1, in the aryl hydrocarbon receptor signaling pathway within cord blood of newborns in
relation to maternal smoking during pregnancy (Joubert et al. 2012). Cigarette smoke also
contributes to reduced histone deacetylase activity, which results in differential activation of
NF-kB and the expression of pro-inflammatory cytokines IL-6 and IL-8 in peripheral lung tissue
(Rahman and Adcock 2006). In pregnancy, the induction of inflammatory genes can influences
placental function and fetal programming (Osei-Kumah et al. 2006).
We hypothesize that a) in utero SHS exposure disturbs early development and disrupt
normal epigenetic regulatory effects on mouse lungs and b) that these alterations remain
detectable in adult lungs and continue to modulate lung responses to various inhaled irritants. To
test this hypothesis, we conducted in utero exposures of pregnant mice to SHS and challenged
their offspring with inhaled irritants, including (recurring) SHS and OVA (Figure 1-6).

Figure 1–6. Overall experimental plan for the SHS-SHS and the SHS-OVA studies.
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This dissertation describes studies involving SHS exposure in utero and the subsequent
irritant challenge on lung function and other lung responses in the adult offspring. The
dissertation is divided into five chapters. Chapter 1 is this introductory chapter. Chapter 2
addresses the lung function and responses of male offspring that had been exposed in utero to
SHS after re-exposure to SHS, as adults. Chapter 3 further explores the duration of the in utero
SHS effect as well as sex-specific differences in response to adult OVA challenge, in a mouse
asthma model. Chapter 4 extends the findings of Chapter 3, but in addition, examines one of the
well-characterized RNA-based epigenetic regulatory factors, miRNA, in OVA-challenged adult
mice that had been exposed in utero to SHS. Chapter 5 is the concluding chapter that
summarizes the advantages of recent technology that has been implemented in the studies
described here, re-addresses important findings, and provides critical and forward-looking
remarks based on these studies.
The majority of this information has been published previously in peer-reviewed journals
as two manuscripts, one covering the information from Chapter 2 (Xiao et al. 2012) and the
other detailing the information from Chapter 3 (Xiao et al. 2013). Chapter 4 has been submitted
for publication and is presently under review.
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CHAPTER 2.
IN UTERO EXPOSURE TO SECOND-HAND SMOKE AGGRAVATES ADULT
RESPONSES TO IRRITANTS: ADULT SECOND-HAND SMOKE1
2.1 Introduction
In utero exposure to second-hand smoke (SHS), which exerts striking effects on lung
function (Lindfors et al. 1999), has been associated with exacerbated asthmatic responses in
children (Lindfors et al. 1999; Mannino et al. 2001). Altered lung function, increased asthma
risk, and persistent lung function deficits in children have been linked with in utero and
postnatal exposure to SHS (Gilliland et al. 2003; Gilliland et al. 2000; Gilliland et al. 2001; Li et
al. 2000; Zlotkowska and Zejda 2005). The synergistic effects of in utero smoke exposure with
various non-tobacco allergens also have been reported. Mild in utero SHS exposure exacerbates
responses of BALB/c mice exposed to ovalbumin (OVA) from 11-15 weeks of age (Penn et al.
2007). These functional, histological and inflammatory responses are accompanied by distinct
changes in lung gene expression (Rouse et al. 2007). Children exposed in utero to maternal
smoking have a higher risk of sensitization to house dust mite (Raherison et al. 2008). A recent
study in mice, found that in utero smoke exposure promotes Th2 polarization and induces
allergic asthma in response to A. fumigatus sensitization (Singh et al. 2011). Whether and how in
utero SHS exposure potentiates subsequent adult physiological and transcriptome responses to
SHS exposure without any other irritant challenge, are not fully understood.
There also is evidence that exposure to environmental pollutants, such as SHS, during
crucial periods of prenatal and/or postnatal development alters the course of lung morphogenesis

1

Reprinted with permission of the American Thoracic Society. Copyright © 2014 American
Thoracic Society. Xiao R, Perveen Z, Paulsen D, Rouse R, Ambalavanan N, Kearney M, Penn
AL. In utero exposure to second-hand smoke aggravates adult responses to irritants: Adult
second-hand smoke. Am J Respir Cell Mol Biol 2012;47(6):843-851.
Official Journal of the American Thoracic Society.
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and maturation, potentially resulting in long-term changes that affect the function and structure
of the respiratory system (Kajekar 2007). Persistent adult SHS exposure is strongly associated
with development of COPD, accounting for more than 80% of COPD cases in the United States
(Sethi and Rochester 2000). The effects of relatively brief SHS exposures in utero on the lung
structure and pathogenesis of COPD have received little attention.
In the experiments described here we tested the hypothesis that in utero exposure to SHS
will aggravate lung responses of young adult mice re-exposed to SHS. We asked whether in
utero and/or adult exposures to SHS have significant effects on mouse lungs with regard to:
 lung inflammation; pro-inflammatory cytokine production
 lung morphology (airway, vasculature)
 lung function, including airway hyperresponsiveness (AHR) and breathing patterns
 gene expression patterns.
We focused particularly on whether mice exposed in utero or as adults to SHS respond
differently from each other and from mice exposed to SHS both in utero and as adults.

2.2 Materials and Methods
Animal protocols. We housed and handled BALB/c mice (Harlan, Indianapolis, IN), as
described previously (Penn et al. 2007). The Louisiana State University Institutional Animal
Care and Use Committee approved all animal procedures. Pregnant mice were housed in
separate cages from Day 20 of pregnancy until weaning (post-natal day 21).
SHS exposures. Sidestream smoke, which comprises 85-90% of SHS, served as a
surrogate for SHS (Bowles et al. 2005; Penn and Snyder 1993). Smoke exposures and related
measurements were as previously described (Penn et al. 2007) except that 3R4F filteredresearch cigarettes (University of Kentucky) were used to achieve a suspended particle density
13

of 10 mg/m3. The 3R4F cigarette is a model of a “full flavor” (10 mg tar) commercially
available filtered cigarette (2012). Investigations carried out with an earlier version of this model
cigarette (1R4F) revealed that the inhalation chamber SHS concentration produced by steadystate combustion of one 1R4F cigarette was exceeded by the SHS concentration in bars where 5
smokers were seated at a table (Penn et al. 1994). In the experiment reported here, pregnant
mice, and subsequently, their male offspring, were exposed in inhalation chambers to a steadystate suspended particle level of 10 mg/m3 and an average carbon monoxide level of 45 ppm,
levels 4-10X higher than those generated in the earlier one cigarette steady-state study.
After 5 days of mating, 10-week-old female mice were exposed to SHS mixed with AIR
or AIR alone (14 air changes/hr, 5 hr/day, 19 consecutive days) in 1.3-m3 stainless steel and
Plexiglass® dynamic exposure chambers. Male offspring were re-exposed to SHS or AIR from
11-15 weeks of age. There were insufficient numbers of female mice produced by these matings
to allow for equivalent size groups of females to be tested. Mice were classified in one of four
groups depending on whether SHS (S) or AIR (A) exposures were in utero or in adults (AA,
N=7; AS, N=8; SA, N=6; SS, N=6). The exposure schedule is presented in Figure 2-1.
Pulmonary function testing. This was carried out as described previously (Penn et al.
2007). In the pulmonary function studies, for each mouse at each methacholine dose level,
readings over 5 minutes were averaged. Penh values represent the degree of AHR in each animal.
These data were used to generate the graph in Figure 2-2A. The highest Penh value (MaxPenh)
recorded for each mouse sampled in the microarray study regardless of the methacholine dose
(Figure 2-6B) is presented along with the array results for that mouse. A similar approach was
used to calculate minimum breathing frequency (MinF; Figure 2-6A).
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Figure 2–1. Group designation and experimental timeline of SHS-SHS study. The two-letter
symbols are assigned to four experimental groups, depending on their exposure status at both time
points. Times shown in the experimental timeline are expressed relative to the birthdate of
offspring. GD, gestation day.
Cytokine quantitation in BALF. Mouse pro-inflammatory cytokine 7-plex kits (MSD,
Meso Scale Discovery, Gaithersburg, MD) were used to measure major pro-inflammatory
cytokines in BALF. The cytokines included in the assay were IL-1b, IL-12p70, IFN-γ, IL-6,
KC/CXCL1, IL-10 and TNF-α. The manufacturer’s stated average limits of detection (based on
multiple kit lots) were 0.75, 35, 0.38, 4.5, 3.3, 11 and 0.85 pg/mL, respectively.
Histopathologic analysis of lungs. After BALF collection, lungs were fixed and
processed as previously described (Bowles et al. 2005; Penn et al. 2007). We used a six-category
scoring system (peribronchial, perivascular, bronchitis, pleuritis, alveolitis, mucus metaplasia)
for evaluation of lung inflammation. The sites were scored from 0 (none) - 4 (severe). A boardcertified veterinary pathologist, blinded to the treatments, evaluated histopathologic samples. A
higher score (maximum score = 24) indicates greater tissue inflammation.
Lung morphometric analysis. Mean linear intercept (MLI) was measured in six 100x
random fields/slide. Radial alveolar count (RAC) was measured in six 100x fields, each of
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which had a bronchiole termination that could be followed out to the pleura. Each value (MLI or
RAC) represents the average of the six fields from each slide (animal) (Ambalavanan et al.
2008). NB: Some RAC measurements had fewer than 6 fields, for we could only identify 4
bronchi in those sections that could be followed out. For vascular morphometry, 20 random
arteries accompanying airways were evaluated. Capillaries (<20µm) or large arteries (>150µm)
were not evaluated. Wall thickness was calculated using the formula (2x [WT/ED] x100%)
where WT = wall thickness; ED = external diameter. We used a Nikon TE2000 microscope
equipped with a QImaging cooled high resolution CCD camera and Metamorph image analysis
software (v 6.2r4) for measurements.
Statistical analysis. We used the SAS statistical package (version 9.1.3; SAS Institute,
Inc., Cary, NC) for data analyses. We performed one-way ANOVA on plethysmograph results,
carried out a Kruskal-Wallis test (one-way ANOVA) on the ranks for the cytokine data, in
considering limits of detection, and a t-test for pairwise-comparison between two combined
groups for morphometric analysis. When significant differences were found in the ANOVA
model, we conducted post hoc pair-wise comparisons with Tukey’s HSD (honest significant
difference) test. In all cases, we considered comparisons significant at P<0.05. All error bars
indicate means ± SEMs.
Lung harvest and mRNA extraction. We followed previously described procedures
(Penn et al. 2007). We checked RNA samples quantity and purity with a NanoDrop ND-1000
Spectrophotometer (NanoDrop, Wilmington, DE). Values generated from the NanoDrop for all
samples fell into the following ranges: 260/280 ratio: 2.13-2.43; 260/230 ratio: 1.95-2.34;
concentration: 622-1283 ng/μL. We performed further quality assays on 1:5 dilutions of RNA
samples with an Agilent 2100 BioAnalyzer and Agilent RNA 6000 Nano Series II Kits (Agilent
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Technologies, Palo Alto, CA). All samples fell into the following ranges: 28S/18S ratio: 1.4-1.6,
RNA integrity number: 8.9-9.6.
Microarray assay. We assessed global gene expression in lungs of individual 15-week
old mice (four male mice per treatment group) on mouse 430.2 genome arrays (Affymetrix,
Santa Clara, CA) representing more than 39,000 transcripts with over 45,000 probe sets. The
arrays were processed at the Research Core Facility of LSU Health Science Center-Shreveport,
as described previously (Penn et al. 2007).
Gene expression profiling. All analyses were performed in R/bioconductor platform
(http://www.r-project.org/; http://www.bioconductor.org/). All 16 arrays were pre-processed
with the Robust Multiarray Average (RMA) method to generate comparable expression values
across all samples. A linear model for 2X2 factorial design ([In Utero Exposure]*[Adult
Exposure]) was constructed with the limma package (Smyth 2004) to select those genes that are
highly associated with in utero and/or adult exposure. Associations between gene expression
and phenotypic variables were tested in phenoTest (Planet 2010). Correlation graphs and heat
maps were plotted using gclus and Heatplus (Ploner 2011) packages. We adopted a red-yellow
color scheme to visualize the relative expression differences across all samples (Figures 2-5, 26B), with red indicating relatively low expression and yellow indicating relatively high
expression. We used a green-red color scheme to indicate fold-change differences for pairwisecomparisons, (Figure 2-7C). The microarray data have been deposited in NCBIs Gene
Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) and are accessible through GEO
Series accession number GSE36810.
Gene-set functional analysis and Ingenuity Pathway Analysis (IPA). Gene-lists
generated from statistical analyses were analyzed in WebGestalt2 (WEB-based Gene SeT
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AnaLysis Toolkit) (Duncan 2010). Degrees of enrichment were calculated based on the genelists with assistance from different public databases, including Gene Ontology (GO), KEGG and
MSigDB. We analyzed gene expression data with Ingenuity Pathways Analysis 8.7; gene
networks and canonical pathways were examined using the Ingenuity Analysis Knowledge
Database (Ingenuity Systems, Redwood City, CA). We created custom gene networks to
demonstrate the connections between the genes and significantly associated functional and
signaling pathways identified in this study.
qRT-PCR. Total RNA was reverse-transcribed with the High Capacity cDNA reverse
transcription kit (Applied Biosystems, Foster City, CA). Expression levels of selected genes
were measured with TaqMan universal PCR master mix (Applied Biosystems) and predesigned
Taqman probes for mouse genes (assay ID: Hprt1, Mm00446968_m1; Gata3, Mm00484683_m1;
Cyp1a1, Mm00487218_m1; Adamts9, Mm00614433_m1; Fam107a, Mm01706977_s1; Egr1,
Mm00656724_m1;

Fos,

Mm00487425_m1

;

Btg2,

Mm00476162_m1;

Zfp36,

Mm00457144_m1; Nr4a1, Mm01300401_m1). The expression levels were normalized to Hprt1
levels.

2.3 Results
Pulmonary function testing. Pulmonary function testing revealed significantly
elevated AHR in the SS group following methacholine challenge, compared to in utero (SA) or
adult (AS) SHS exposure alone (Figure 2-2A). A reverse trend was found for breathing
frequency (Figure 2-2B). Significant differences (Tukey’s, P<0.05) were found in enhanced
pause (Penh) and breathing frequency (f) between the SS group and the other three groups at the
highest methacholine dose (50 mg/ml). At methacholine doses ≤12 mg/ml, both AS and SS
groups had higher responses than the SA and AA groups (both exposed to AIR as adults)
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whereas further increases in methacholine dose differentiated the SS group from the AS group
and even more from the other two groups.

Figure 2–2. The SHS-SHS group exhibited significantly increased AHR and decreased breathing
frequency, compared with in utero or adult SHS exposure alone. Whole-body plethysmography
showed significantly increased AHR (Penh) and decreased breathing frequency (f) in mice twiceexposed to SHS, compared with those exposed either only in utero or as adults. Significant
differences (ANOVA, P<0.05) were found in Penh (all methacholine doses) and f (only 50
mg/ml); post hoc Tukey’s test indicates the differences are between SS and all other groups when
treated with mechacholine 50 mg/ml. Values are represented as the means ± SEMs.
Levels of BALF cytokines. IL-1b, IL-6 and KC/CXCL1 were low, but were
significantly increased (Tukey’s, P<0.05) in the SS group compared to the other three groups
(Figure 2-3). IL-10, IL-12p70, TNF- α and IFN-γ were not detected in any samples. Neutrophil
levels in cell differentials were very low in all 4 groups and indistinguishable from each other
(data not presented).
Lung morphometric analysis. We assessed mean linear intercept (MLI), radial
alveolar count (RAC) and vascular morphometric parameters, including arterial wall thickness
(WT), artery external diameter (ED), and percentage wall thickness (% WT; Figure 2-4A).
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Figure 2–3. The SHS-SHS group had significantly higher levels of BALF cytokines, including IL1b, IL-6, KC/CXCL1, compared with only in utero or adult SHS exposures. Mice in the SS group
had significantly higher levels of the cytokines IL-1b, IL-6 and KC/CXCL1, compared with mice
in the other three groups (ANOVA on ranks, P<0.05; post hoc Holm-Sidak’s test). There was no
detectable IL-10, IL-12p70 or IFN-γ in any group. All bars represent the means ± SEMs.

Figure 2–4. In utero but not adult exposure, significantly affected lung morphometric results in
15-week male mice. Upper panels showed significantly increased MLI and increased pulmonary
arterial WT and ED in groups exposed in utero to SHS. Each bar represents the mean ± SEM.
Representative slides displayed on the bottom panels showed increased collagen deposition
(indicated by pink collagen fibers) around pulmonary arteries in AS and SS groups. A: artery. Br:
bronchiole.

20

We found no statistically significant differences when results for the four individual
groups were compared, although there were indications of in utero exposure-related responses.
After re-grouping the four groups into two groups according to their in utero exposure status,
there were significant increases in MLI, WT and ED in SX vs AX mice (SX: SA&SS combined,
N=12; AX: AA&AS combined, N=15; Tukey’s, P<0.05). There was evidence of increased
perivascular collagen deposition in AS and SS groups (Figure 2-4B).
Gene expression profiling. Via a linear model, gene expression profiling revealed three
sets of genes that were uniquely affected by in utero SHS exposure (N=232), adult SHS
exposure (N=5547) or both in utero and adult SHS exposures (N=183), as shown in the Venn
diagram in Figure 2-5. All genes in each group had P-values and FDR values<0.05. Adult
exposure to SHS yielded 20X more differentially expressed genes than did in utero SHS
exposure. Relatively low (red) or high (yellow) expression levels across all samples were plotted
in heat maps and confirmed that in each case the gene expression patterns were dependent on the
timing of SHS exposure (Figure 2-5).
The correlation scatterplot revealed that cytokine levels correlated well with
physiological measurements (Figure 2-6A). The measurement with the highest correlation was
of MaxPenh (r(IL-1b,MaxPenh)=0.66, r(IL-6,MaxPenh)=0.83). Therefore, we selected MaxPenh to
represent AHR, and correlated this set of readings with each gene on the microarray. We found
323 probes, each with P-value and FDR <0.05. All 323 probes were plotted in a heat map, with
MaxPenh values also shown below the heat map (Figure 2-6B).
For each of the four gene-lists (in utero only; adult only; in utero+adult (Figure 2-5); and
AHR (Figure 2-6B)), the 10 most up/down-regulated genes (SS vs AA, i.e., doubly exposed to
SHS vs never exposed) in each list are presented in Figure 2-7A. Differential expression of
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several genes initially identified by microarray analysis, and highlighted in Figure 2-7A, was
further confirmed by qRT-PCR. The ΔΔCT values (for the gene of interest compared to the
housekeeping gene, Hprt1) are charted in Figure 2-7B. For each comparison, the Hprt1 value is
set at zero. An absolute difference of one in the units on the y-axis indicates a 2-fold difference
in expression.

Figure 2–5. Transcriptome screening in lungs of 15-week old male mice revealed subsets of genes
that are associated predominantly with A) in utero SHS exposure, B) adult SHS exposure and C)
mixed effect of both. The Venn diagram shows numbers of probes found significantly expressed
for each exposure period (FDR <0.05). Heat maps show the expression pattern of probes in each
portion of the Venn diagram. For the adult exposure effect (>5000 probes), 226 gene-probes with
FDR <0.001 are presented.
We found a minimum fold-change of two for all the genes charted in Figure 2-7B,
including in utero exposure-affected genes (Egr1, Fos), both (in utero and adult) exposureaffected genes (Btg2, Zfp36, Nr4a1) and AHR-associated genes (Gata3, Fam107a, Cyp1a1,
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Adamts9). The high correlation between AHR responses and SS exposures is reflected in the
relative expression levels of Fam107, Cyp1a1 and Adamts9.

Figure 2–6. The physiological and cytokine measurements were highly correlated and can be
associated with subsets of genes through microarray analysis. A) All readings in the same units as
in other figures, e.g., pg/mL for cytokines, are plotted to interrogate the correlation between every
two parameters (color of each dot: AA=blue, AS=red, SA=green, SS=purple). All measurements
had a fairly high correlation with each other (|r|>0.5. The background color of each scatterplot
indicates the degree of correlation: blue=moderate; red=high). B) 323 gene-probes, significantly
correlated with AHR (represented by MaxPenh values), are shown in a heat map with each
animal’s MaxPenh values plotted below (actual dots with a smoothed line). The correlation graph
was plotted with the gclus package in R/bioconductor (see Methods).
In utero SHS exposure identified genes primarily associated with immune system
processes (GO:0002376, P-value=1.18E-8; FDR=5.92E-6), most of which are not responsive to
adult SHS exposure. The most striking KEGG pathways of adult exposure-affected genes are
“Circadian rhythm–mammal” (P-value=2.59E-07; FDR=4.40E-05), “MAPK signaling pathway”
(P-value=0.0005; FDR=0.0340) and “Pathways in cancer” (P-value=0.0006; FDR=0.0340).
These significant processess and pathways are listed in Table 2-1 and Table 2-2.
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Table 2–1. In utero SHS exposure identified genes primarily associated with immune system
processes.
biological process----immune system process----GO:0002376
C=720;O=25;E=6.87;R=3.64;rawP=1.18e-08;adjP=5.92e-06
AffyID
Entrez GeneSymbol Description
1417065_at
13653 Egr1
early growth response 1
1419135_at
16994 Ltb
lymphotoxin B
1423135_at
21838 Thy1
thymus cell antigen 1, theta
1439902_at
12273 C5ar1
complement component 5a receptor 1
1422190_at
12273 C5ar1
complement component 5a receptor 1
1417025_at
14969 H2-Eb1
histocompatibility 2, class II antigen E beta
1449580_s_at
15000 H2-DMb2
histocompatibility 2, class II, locus Mb2
1419744_at
15000 H2-DMb2
histocompatibility 2, class II, locus Mb2
1418830_at
12518 Cd79a
CD79A antigen (immunoglobulin-associated alpha)
1456354_at
11438 Chrna4
cholinergic receptor, nicotinic, alpha polypeptide 4
1451383_a_at
12675 Chuk
conserved helix-loop-helix ubiquitous kinase
1418261_at
20963 Syk
spleen tyrosine kinase
1425797_a_at
20963 Syk
spleen tyrosine kinase
1417574_at
20315 Cxcl12
chemokine (C-X-C motif) ligand 12
1425412_at
216799 Nlrp3
NLR family, pyrin domain containing 3
1437304_at
208650 Cblb
Casitas B-lineage lymphoma b
1449127_at
20345 Selplg
selectin, platelet (p-selectin) ligand
1422122_at
14128 Fcer2a
Fc receptor, IgE, low affinity II, alpha polypeptide
1429319_at
74734 Rhoh
ras homolog gene family, member H
1416016_at
16912 Psmb9
proteasome (prosome, macropain) subunit, beta type 9
(large multifunctional peptidase 2)
1448452_at
15900 Irf8
interferon regulatory factor 8
1417867_at
11537 Cfd
complement factor D (adipsin)
1419282_at
20293 Ccl12
chemokine (C-C motif) ligand 12
1416246_a_at
12721 Coro1a
coronin, actin binding protein 1A
1460188_at
15170 Ptpn6
protein tyrosine phosphatase, non-receptor type 6
1435221_at
108655 Foxp1
forkhead box P1
1452514_a_at
16590 Kit
kit oncogene
1415900_a_at
16590 Kit
kit oncogene
1419631_at
22376 Was
Wiskott-Aldrich syndrome homolog (human)
Table 2–2. The most striking KEGG pathways of adult exposure-affected genes are “Circadian
rhythm–mammal”, “MAPK signaling pathway” and “Pathways in cancer”.
KEGG pathway----Circadian rhythm - mammal----04710
C=13;O=11;E=2.28;R=4.83;rawP=2.59e-07;adjP=4.40e-05
AffyID
Entrez GeneSymbol Description
1418889_a_at 104318 Csnk1d
casein kinase 1, delta
1435775_at
12753 Clock
circadian locomoter output cycles kaput
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(Table 2–2 continued)
AffyID
Entrez
1417176_at
27373
1417175_at
27373
1417602_at
18627
1417603_at
18627
1418025_at
20893
1449851_at
18626
1425099_a_at 11865
1426383_at
12953
1421099_at
79362
1421037_at
18143
1433733_a_at 12952

GeneSymbol
Csnk1e
Csnk1e
Per2
Per2
Bhlhe40
Per1
Arntl
Cry2
Bhlhe41
Npas2
Cry1

Description
casein kinase 1, epsilon
casein kinase 1, epsilon
period homolog 2 (Drosophila)
period homolog 2 (Drosophila)
basic helix-loop-helix family, member e40
period homolog 1 (Drosophila)
aryl hydrocarbon receptor nuclear translocator-like
cryptochrome 2 (photolyase-like)
basic helix-loop-helix family, member e41
neuronal PAS domain protein 2
cryptochrome 1 (photolyase-like)

KEGG pathway----MAPK signaling pathway----04010
C=251;O=65;E=43.98;R=1.48;rawP=0.0005;adjP=0.0340
AffyID
Entrez GeneSymbol Description
1460393_a_at 235584 Dusp7
dual specificity phosphatase 7
1440210_at
12300 Cacng2
calcium channel, voltage-dependent, gamma subunit 2
1428473_at
19056 Ppp3cb
protein phosphatase 3, catalytic subunit, beta isoform
1420554_a_at 170758 Rac3
RAS-related C3 botulinum substrate 3
1450698_at
13537 Dusp2
dual specificity phosphatase 2
1417268_at
12475 Cd14
CD14 antigen
1439258_at
11911 Atf4
activating transcription factor 4
1448135_at
11911 Atf4
activating transcription factor 4
1423462_at
68652 Map3k7ip2
mitogen-activated protein kinase kinase kinase 7
interacting protein 2
1459770_at
216965 Taok1
TAO kinase 1
1459996_at
12286 Cacna1a
calcium channel, voltage-dependent, P/Q type, alpha 1A
subunit
1454369_a_at 73181 Nfatc4
nuclear factor of activated T-cells, cytoplasmic,
calcineurin-dependent 4
1416703_at
26416 Mapk14
mitogen-activated protein kinase 14
1416437_a_at 30957 Mapk8ip3
mitogen-activated protein kinase 8 interacting protein 3
1455597_at
26405 Map3k2
mitogen-activated protein kinase kinase kinase 2
1455758_at
18752 Prkcc
protein kinase C, gamma
1448689_at
66922 Rras2
related RAS viral (r-ras) oncogene homolog 2
1449114_at
56274 Stk3
serine/threonine kinase 3 (Ste20, yeast homolog)
1458226_at
286940 Flnb
filamin, beta
1439004_at
73086 Rps6ka5
ribosomal protein S6 kinase, polypeptide 5
1420584_at
18781 Pla2g2c
phospholipase A2, group IIC
1440619_at
19099 Mapk8ip1
mitogen-activated protein kinase 8 interacting protein 1
1452116_s_at 11909 Atf2
activating transcription factor 2
1434785_at
140723 Cacng5
calcium channel, voltage-dependent, gamma subunit 5
1449839_at
12367 Casp3
caspase 3
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(Table 2–2 continued)
AffyID
Entrez
1426165_a_at 12367
1424852_at
17260
1421027_a_at 17260
1423478_at
18751
1460251_at
14102
1427853_a_at 15507
1426032_at
18019

GeneSymbol
Casp3
Mef2c
Mef2c
Prkcb
Fas
Hspb1
Nfatc2

1419532_at
1460420_a_at
1436602_x_at

16178
13649
12287

Il1r2
Egfr
Cacna1b

1421953_at
1425796_a_at
1421841_at
1449545_at
1449117_at
1454184_a_at
1441482_at
1453851_a_at
1420931_at
1416505_at
1448830_at
1456467_s_at
1435970_at
1429128_x_at

12929
14184
14184
14172
16478
16150
26399
23882
26419
15370
19252
18099
18099
18034

Crkl
Fgfr3
Fgfr3
Fgf18
Jund
Ikbkb
Map2k6
Gadd45g
Mapk8
Nr4a1
Dusp1
Nlk
Nlk
Nfkb2

1422999_at
1421376_at
1417409_at
1448694_at
1426898_at

53859
22034
16476
16476
66513

Map3k14
Traf6
Jun
Jun
Map3k7ip1

1451502_at
1431182_at
1415834_at
1421107_at
1434159_at
1421925_at
1449901_a_at
1422785_at
1455181_at
1418256_at
1418255_s_at

26565
15481
67603
58231
58231
19094
53608
114713
114713
20807
20807

Pla2g10
Hspa8
Dusp6
Stk4
Stk4
Mapk11
Map3k6
Rasa2
Rasa2
Srf
Srf

Description
caspase 3
myocyte enhancer factor 2C
myocyte enhancer factor 2C
protein kinase C, beta
Fas (TNF receptor superfamily member 6)
heat shock protein 1
nuclear factor of activated T-cells, cytoplasmic,
calcineurin-dependent 2
interleukin 1 receptor, type II
epidermal growth factor receptor
calcium channel, voltage-dependent, N type, alpha 1B
subunit
v-crk sarcoma virus CT10 oncogene homolog (avian)-like
fibroblast growth factor receptor 3
fibroblast growth factor receptor 3
fibroblast growth factor 18
Jun proto-oncogene related gene d
inhibitor of kappaB kinase beta
mitogen-activated protein kinase kinase 6
growth arrest and DNA-damage-inducible 45 gamma
mitogen-activated protein kinase 8
nuclear receptor subfamily 4, group A, member 1
dual specificity phosphatase 1
nemo like kinase
nemo like kinase
nuclear factor of kappa light polypeptide gene enhancer in
B-cells 2, p49/p100
mitogen-activated protein kinase kinase kinase 14
TNF receptor-associated factor 6
Jun oncogene
Jun oncogene
mitogen-activated protein kinase kinase kinase 7
interacting protein 1
phospholipase A2, group X
heat shock protein 8
dual specificity phosphatase 6
serine/threonine kinase 4
serine/threonine kinase 4
mitogen-activated protein kinase 11
mitogen-activated protein kinase kinase kinase 6
RAS p21 protein activator 2
RAS p21 protein activator 2
serum response factor
serum response factor
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(Table 2–2 continued)
AffyID
Entrez
1436522_at
26406
1425911_a_at 14182
1416272_at
56692
1418497_at
14168
1446798_at
225028
1420442_at
12292

GeneSymbol
Map3k3
Fgfr1
Mapksp1
Fgf13
Map4k3
Cacna1s

1417631_at
1418401_a_at
1434295_at

Mknk1
Dusp16
Rasgrp1

17346
70686
19419

Description
mitogen-activated protein kinase kinase kinase 3
fibroblast growth factor receptor 1
MAPK scaffold protein 1
fibroblast growth factor 13
mitogen-activated protein kinase kinase kinase kinase 3
calcium channel, voltage-dependent, L type, alpha 1S
subunit
MAP kinase-interacting serine/threonine kinase 1
dual specificity phosphatase 16
RAS guanyl releasing protein 1

KEGG pathway----Pathways in cancer----05200
C=309;O=77;E=54.14;R=1.42;rawP=0.0006;adjP=0.0340
AffyID
Entrez GeneSymbol Description
1420554_a_at 170758 Rac3
RAS-related C3 botulinum substrate 3
1455214_at
17342 Mitf
microphthalmia-associated transcription factor
1460657_at
22409 Wnt10a
wingless related MMTV integration site 10a
1436267_a_at 56717 Mtor
mechanistic target of rapamycin (serine/threonine kinase)
1425377_at
22408 Wnt1
wingless-related MMTV integration site 1
1450117_at
21415 Tcf7l1
transcription factor 7-like 2 (T-cell specific, HMG box)
1453134_at
18706 Pik3ca
phosphatidylinositol 3-kinase, catalytic, alpha polypeptide
1425918_at
112407 Egln3
EGL nine homolog 3 (C. elegans)
1455758_at
18752 Prkcc
protein kinase C, gamma
1436791_at
22418 Wnt5a
wingless-related MMTV integration site 5A
1427265_at
110279 Bcr
breakpoint cluster region
1455564_at
110279 Bcr
breakpoint cluster region
1418208_at
18510 Pax8
paired box gene 8
1422912_at
12159 Bmp4
bone morphogenetic protein 4
1428725_at
17344 Pias2
protein inhibitor of activated STAT 2
1456482_at
18710 Pik3r3
phosphatidylinositol 3 kinase, regulatory subunit,
polypeptide 3 (p55)
1418587_at
22031 Traf3
TNF receptor-associated factor 3
1428853_at
19206 Ptch1
patched homolog 1
1442884_at
15234 Hgf
hepatocyte growth factor
1451866_a_at 15234 Hgf
hepatocyte growth factor
1449839_at
12367 Casp3
caspase 3
1426165_a_at 12367 Casp3
caspase 3
1423478_at
18751 Prkcb
protein kinase C, beta
1427718_a_at 17246 Mdm2
transformed mouse 3T3 cell double minute 2
1460251_at
14102 Fas
Fas (TNF receptor superfamily member 6)
1450034_at
20846 Stat1
signal transducer and activator of transcription 1
1420915_at
20846 Stat1
signal transducer and activator of transcription 1
1421942_s_at 21802 Tgfa
transforming growth factor alpha
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(Table 2–2 continued)
AffyID
Entrez
1420888_at
12048
1426050_at
12048
1443197_at
22412
1456529_at
56458
1460420_a_at 13649
1422162_at
13176
1422129_at
23805
1421953_at
12929
1441737_s_at 56289
1425796_a_at 14184
1421841_at
14184
1423886_at
226519
1449545_at
14172
1416533_at
112406
1450525_at
14634
1420892_at
22422
1427640_a_at 12395

GeneSymbol
Bcl2l1
Bcl2l1
Wnt9b
Foxo1
Egfr
Dcc
Apc2
Crkl
Rassf1
Fgfr3
Fgfr3
Lamc1
Fgf18
Egln2
Gli3
Wnt7b
Runx1t1

1440310_at

12395

Runx1t1

1448785_at

12395

Runx1t1

1437784_at

12395

Runx1t1

1429428_at
1424113_at
1427638_at
1439163_at
1454184_a_at
1420931_at
1436000_a_at
1460247_a_at
1437033_a_at
1418969_at
1458904_at
1417301_at
1420088_at

21416
16777
235320
235320
16150
26419
27401
27401
27401
27401
14368
14368
18035

Tcf7l2
Lamb1-1
Zbtb16
Zbtb16
Ikbkb
Mapk8
Skp2
Skp2
Skp2
Skp2
Fzd6
Fzd6
Nfkbia

1420089_at

18035

Nfkbia

1449731_s_at

18035

Nfkbia

1448306_at

18035

Nfkbia

Description
BCL2-like 1
BCL2-like 1
wingless-type MMTV integration site 9B
forkhead box O1
epidermal growth factor receptor
deleted in colorectal carcinoma
adenomatosis polyposis coli 2
v-crk sarcoma virus CT10 oncogene homolog (avian)-like
Ras association (RalGDS/AF-6) domain family member 1
fibroblast growth factor receptor 3
fibroblast growth factor receptor 3
laminin, gamma 1
fibroblast growth factor 18
EGL nine homolog 2 (C. elegans)
GLI-Kruppel family member GLI3
wingless-related MMTV integration site 7B
runt-related transcription factor 1; translocated to, 1
(cyclin D-related)
runt-related transcription factor 1; translocated to, 1
(cyclin D-related)
runt-related transcription factor 1; translocated to, 1
(cyclin D-related)
runt-related transcription factor 1; translocated to, 1
(cyclin D-related)
transcription factor 7-like 2, T-cell specific, HMG-box
laminin B1 subunit 1
zinc finger and BTB domain containing 16
zinc finger and BTB domain containing 16
inhibitor of kappaB kinase beta
mitogen-activated protein kinase 8
S-phase kinase-associated protein 2 (p45)
S-phase kinase-associated protein 2 (p45)
S-phase kinase-associated protein 2 (p45)
S-phase kinase-associated protein 2 (p45)
frizzled homolog 6 (Drosophila)
frizzled homolog 6 (Drosophila)
nuclear factor of kappa light polypeptide gene enhancer in
B-cells inhibitor, alpha
nuclear factor of kappa light polypeptide gene enhancer in
B-cells inhibitor, alpha
nuclear factor of kappa light polypeptide gene enhancer in
B-cells inhibitor, alpha
nuclear factor of kappa light polypeptide gene enhancer in
B-cells inhibitor, alpha
28

(Table 2–2 continued)
AffyID
Entrez
1417360_at
17350
1429128_x_at 18034

GeneSymbol
Mlh1
Nfkb2

1418861_at
1418534_at
1421376_at
1417409_at
1448694_at
1421359_at
1420957_at
1420956_at
1427650_a_at
1440739_at
1421107_at
1434159_at
1447888_x_at
1440764_at
1426587_a_at
1424272_at
1455689_at
1445452_at
1427567_a_at
1436983_at
1420715_a_at
1425911_a_at
1448861_at
1418497_at
1455604_at
1434705_at
1424638_at
1421679_a_at
1427190_at

59004
57265
22034
16476
16476
19713
11789
11789
12394
22341
58231
58231
17685
11836
20848
20848
93897
22029
59069
12914
19016
14182
22033
14168
14367
13017
12575
12575
72993

Pias4
Fzd2
Traf6
Jun
Jun
Ret
Apc
Apc
Runx1
Vegfc
Stk4
Stk4
Msh2
Araf
Stat3
Stat3
Fzd10
Traf1
Tpm3
Crebbp
Pparg
Fgfr1
Traf5
Fgf13
Fzd5
Ctbp2
Cdkn1a
Cdkn1a
Appl1

1436116_x_at

72993

Appl1

1455886_at
1425594_at

12402
23928

Cbl
Lamc3

Description
mutL homolog 1 (E. coli)
nuclear factor of kappa light polypeptide gene enhancer in
B-cells 2, p49/p100
protein inhibitor of activated STAT 4
frizzled homolog 2 (Drosophila)
TNF receptor-associated factor 6
Jun oncogene
Jun oncogene
ret proto-oncogene
adenomatosis polyposis coli
adenomatosis polyposis coli
runt related transcription factor 1
vascular endothelial growth factor C
serine/threonine kinase 4
serine/threonine kinase 4
mutS homolog 2 (E. coli)
v-raf murine sarcoma 3611 viral oncogene homolog
signal transducer and activator of transcription 3
signal transducer and activator of transcription 3
frizzled homolog 10 (Drosophila)
TNF receptor-associated factor 1
tropomyosin 3, gamma
CREB binding protein
peroxisome proliferator activated receptor gamma
fibroblast growth factor receptor 1
TNF receptor-associated factor 5
fibroblast growth factor 13
frizzled homolog 5 (Drosophila)
C-terminal binding protein 2
cyclin-dependent kinase inhibitor 1A (P21)
cyclin-dependent kinase inhibitor 1A (P21)
adaptor protein, phosphotyrosine interaction, PH domain
and leucine zipper containing 1
adaptor protein, phosphotyrosine interaction, PH domain
and leucine zipper containing 1
Casitas B-lineage lymphoma
laminin gamma 3

We further combined the in utero exposure-affected gene-list with the AHR associated
gene-list and searched for distinct signaling pathways from the newly generated gene-list in IPA.
The enriched canonical pathways found included: “IL-17A Signaling in Fibroblasts” (P29

value=2.24E-4) and “Production of Nitric Oxide and Reactive Oxygen Species in Macrophages”
(P-value=2.09E-3). By connecting genes with reported gene interactions and known biological
function, a composite gene network was built and is displayed in Figure 2-7C. The additional
two IPA-designated biological functions shown in Figure 2-7C are “Inflammation” (Pvalue=1.02E-8) and “hypersensitive reaction” (P-value=1.1E-8). Genes associated with the IL17A signaling pathway, including Cebpd, Nfkbia, Ccl2 and Fos also appear in the inflammation
and reactive oxygen species pathways (Figure 2-7C).

2.4 Discussion
The experiments described here demonstrate that in utero exposure to environmentallyrelevant levels of SHS modulates adult responses to subsequent SHS exposures. Male BALB/c
mice exposed to SHS both in utero and as adults exhibited significantly elevated lung
morphometry, pulmonary function and gene expression responses compared with the other three
groups. Somewhat surprisingly, none of these changes appeared to be driven by inflammatory
processes. Although levels of the pro-inflammatory cytokines IL-1b, IL-6 and KC/CXCL1 were
significantly elevated in BAL fluid of the SS mice, the levels of each (IL-1b= 2.7; IL-6=7.9;
KC/CXCL1=49.5 pg/mL; Figure 2-3) were near the low end of their respective linear response
well reflect an overall weak cytokine response to the SHS exposures. The absence of grossly
visible inflammation or increased immune cell infiltration in all four groups is consistent with
this.
Morphometric analysis provided quantitative values for evaluation of lung structural
changes in response to SHS exposures. The lack of significant statistical differences between the
4 groups before pooling likely reflects the relatively low “N”s in each group (6-8). Further
statistical analysis identified significant differences after regrouping mice into two groups,
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Figure 2–7. Differentially expressed genes were confirmed by qRT-PCR and interrogated by
Ingenuity Pathway Analysis. A) Microarray fold-changes between SS and AA (doubly exposed to
SHS vs never exposed) are listed for the 10 most up/down-regulated genes that were found in
each of the four gene sets. Genes highlighted in red were confirmed by qRT-PCR. B) qRT-PCR
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performed on 9 genes confirmed the microarray-based findings. Data (y-axis) are presented as –
ΔΔCT values so that calculated values are positively associated with the gene expression levels.
For each comparison, the Hprt1 value is set at zero. C) Genes affected by in utero exposure and
those highly correlated with AHR were inter-connected in IPA Pathway Designer and found to be
significantly associated with several known biological functions and canonical pathways (P<0.05).
Thickened dark green edges indicate significant down-regulation due to in utero SHS exposure
(SX vs AX); colors inside each node indicate gene expression changes with increased AHR (SS
vs SA, red/green=up/down-regulation).
according to their in utero exposure status. Mice exposed in utero to SHS (SA,SS) had higher
MLI values than those exposed to AIR in utero (AA,AS); this suggests airspace enlargement in
mice exposed in utero to SHS. In addition, wall thickness and external diameter of random
selected medium-sized arteries were significantly increased in animals exposed in utero to SHS.
Together, these data indicate a role for in utero exposure to SHS on lung development that is
sustained into adulthood. In this case, the effects of 2 weeks of in utero exposure (SA, SS)
outweigh the effects of 4 weeks of adult SHS (AS).
Increased collagen deposition around pulmonary arteries in the AS and SS groups
(Figure 2-4) suggests that adult exposure results in production of more ECM proteins, which
would ultimately be necessary for development of lung fibrosis and COPD. The pathogenesis of
COPD is associated with an imbalance of metalloproteases (MMP, ADAM) and antimetalloproteases (TIMP, alpha-2M) (Mocchegiani et al. 2011). In the present study, there was
notable up-regulation of metalloprotease family genes, including Adamts9 and Mmp3 in the SS
and AHR groups (2-4X increase). Up-regulation of both of these genes has been associated with
lung fibrosis. Adamts9 up-regulation and associated collagen deposition have been reported in a
TGF-beta stimulated model of lung fibrosis (Keating et al. 2006). The collagen-deposition was
reduced in alveolar epithelial cells transfected with Adamts9 siRNA. Paraquat-induced lung
fibrosis in mice also is associated with Mmp3 up-regulation (Tomita et al. 2007). In addition to
lung structural changes, in utero SHS exposure may have an effect on COPD pathogenesis. An
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epidemiological study in 2009 linked maternal smoke exposure to further impaired lung function
in offspring even in late adulthood, when COPD becomes apparent; and further, that maternal
smoke exposure aggravates the cumulative effect of active cigarette consumption (Beyer et al.
2009). Together, these results suggest that early life smoke exposure may serve as a risk factor
for the pathogenesis of COPD.
Lung function testing revealed that the SS group was more responsive than the other
three groups at the highest methacholine dose, 50 mg/ml, in terms of both Penh and breathing
frequency. Although Penh does not directly reflect airway mechanical function (Hamelmann et
al. 1997), it has been used as an indicator of AHR and has been shown to correlate well with
lung resistance in BALB/c mice (DeLorme and Moss 2002; Singh et al. 2003). Together with
the

observed

reduction

in

breathing

frequency,

likely

an

adaptive

response

to

bronchoconstriction (Adler et al. 2004), these results strongly support a significantly enhanced
airway response in the group that has been exposed to SHS both in utero and as adults. An
earlier report described similar results in rats exposed in utero and then postnatally to SHS.
There was significantly increased lung resistance compared to SHS exposure at one time-point
only, at 7-10 weeks of age (Joad et al. 1995).
Gene expression profiling with a linear model, revealed that the most differentiallyexpressed genes associated with in utero SHS exposure are Fos, Egr1 and Cyr61, all of which
are down-regulated >2X; these results were confirmed by qRT-PCR (Figure 2-7B). In adults,
up-regulation of these three genes has been associated with COPD progression (Ning et al.
2004). Egr1, a zinc finger transcription factor, has been suggested to play a key role in
development of cigarette smoke-induced COPD by regulating MMP activity, and then affecting
the turnover of ECM proteins during the pathogenesis of COPD (Reynolds et al. 2006). Fos is a
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important component of AP-1, a redox-sensitive transcription factor, which interacts with Nrf2
(nuclear factor erythroid-derived 2, like 2) and regulates cytoprotective enzymes, including HO1 (heme oxygenase) (Baglole et al. 2008). Reduction in Fos expression induced by cigarette
smoke may interfere with protection against oxidative stress. Two other genes with ~2-fold
down-regulation following in utero SHS exposure are Fcer2 and Pde4b, both of which have
SNPs linked to increased risks of asthma and COPD. Fcer2 (Fc fragment of IgE, low-affinity II
receptor) encodes the low-affinity IgE receptor, CD23, which is a key regulator in the biologic
actions of IgE-mediated hypersensitivity commonly found in asthma patients (Tantisira et al.
2007). Pde4b, which encodes the cAMP-specific 3', 5'-cyclic phosphodiesterase 4B, has been
identified as an essential molecule for Th2 cell function and development of AHR in allergic
asthma (Jin et al. 2010).
The decreased expression here of Fos, Egr1 and Cyr61 in mice exposed in utero to SHS
contrasts with clinical and experimental findings from adult mainstream smoke exposures, noted
in the previous paragraph, that have linked elevated expression of these genes with the
progression of asthma or COPD. Clearly, suppressed expression of these genes associated with
in utero SHS exposure did not protect against indicators of these diseases here, as more
airspaces are found in the SA and SS groups and significantly increased AHR is observed in the
SS group. In addition, up-regulation of the pro-fibrotic Adamts9 and Mmp3 in lungs of SSexposed adult mice also is consistent with a COPD-promotion effect.The possibility of a
relationship between gestational SHS exposure and subsequent development of COPD has
apparently not been previously examined. Alternatively, the unexpected down-regulation of Fos,
Egr1 and Cyr61 despite the accompanying increases in airspaces, collagen deposition and AHR
in lungs of adult mice exposed in utero to SHS may simply be consistent with the view that
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there are no good animal models of cigarette smoke-associated COPD (Churg et al. 2011).
Although the approach we adopted successfully selected candidate genes according to
how closely they matched the smoke exposure conditions, the gene expression results we
observed relating to whole-body plethysmography and cytokine responses were markedly
enhanced only in animals exposed to SHS both in utero and as adults (Figure 2-6). To identify
the genes closely correlated with the prominent SS-response, MaxPenh, the most prominent of
the functional lung responses, was selected as the response variable, to which gene expression
changes were compared. One of the merits of this approach is that the gene-response correlation
values were calculated regardless of the group in which each sample resided, so the in-group
variation will not negatively affect the test results. This is illustrated in the sample labeled
“29AS” where the high AHR response in an otherwise low AHR group is correlated with levels
of gene expression comparable to those found in all 4 mice in the high AHR SS group (Figure 26B).
To further investigate how in utero SHS exposure may contribute to exacerbated adult
responses, we combined the lists of in utero only exposure-affected genes with AHR-associated
genes and interrogated signaling pathways from this new gene-list. From IPA, the AHRassociated genes were recognized to be significantly associated with increased inflammation,
oxidative stress and hypersensitivity reactions. Although the fold-change values (SS vs SA,
highest vs lowest AHR, see Figure 2-2 and Figure 2-6B) in the gene network are moderate
(1.5X-2.8X), they all are from genes modulated by in utero SHS exposure, and retained until 15
weeks of age.
In addition, IL-17 signaling, one of the most significant canonical pathways identified in
IPA with in utero exposure (P-value=6.12E-03) as well as with both exposures (P-value=2.05E35

03), may also partially explain the prominent SS-response that originates from in utero SHS
exposures. As fetal T cells develop during the second trimester of gestation (Papiernik 1970),
the cytokine level changes are detected not only in the circulating blood of the pregnant mothers,
but also in amniotic fluids with direct contact to the fetal lungs (Mandal et al. 2011). The
elevated circulating level of TGF-beta during gestation promotes development of regulatory T
cells (Treg cells); however, in utero SHS exposure also increases the level of IL-6, and naïve T
cells will differentiate into Th17 cells in the presence of both TGF-beta and IL-6 (Bettelli et al.
2006). In addition, the aryl hydrocarbon receptor, which is activated by the polynuclear aromatic
hydrocarbons (PAHs) generated by cigarette smoking, was reported to also have regulatory
functions in Th17 cell populations (Kimura et al. 2008; Quintana et al. 2008; Veldhoen et al.
2008). During the critical developmental period, the immune cell lineage commitment may
greatly affect the lung responses of the offspring even when they become adults (Martino and
Prescott 2010).
Summary: We examined lung responses of BALB/c mice to in utero and/or adult
exposures to environmentally-relevant levels of SHS. There were significant increases in AHR
and in pro-inflammatory cytokine production (IL-1b, IL-6, KC/CXCL1), albeit at low levels, in
lungs of 15-week old doubly-exposed mice. There were enlarged airspaces and arteries in mice
exposed in utero to SHS, plus increased collagen deposition in mice exposed to SHS as adults.
Unique gene expression patterns were apparent for in utero, adult and combined exposures.
Overall, the results indicate that in utero SHS exposures alter lung structure more severely than
do adult SHS exposures of longer duration, aggravate AHR and promote a pro-fibrotic milieu in
adult lungs.
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CHAPTER 3.
IN UTERO EXPOSURE TO SECOND-HAND SMOKE AGGRAVATES ADULT
RESPONSES TO IRRITANTS: ADULT OVALBUMIN2
3.1 Introduction
Second-hand smoke (SHS) exposure in utero aggravates responses to subsequent postnatal exposures to environmental irritants, including house dust mites (Raherison et al. 2008),
Aspergillus fumigatus (Singh et al. 2009) and SHS (Xiao et al. 2012). The most common
observation among these studies is increased airway hyper-responsiveness (AHR), a hallmark of
allergic asthma.
In the murine model of asthma featuring ovalbumin (OVA) sensitization and challenge,
OVA-induced lymphocyte infiltration, elevated Th2 cytokine production, and increased AHR
mirror several key characteristics of asthma (Kips et al. 2003; Lloyd 2007; Nials and Uddin
2008; Temelkovski et al. 1998). Whether and how in utero exposure to SHS affects responses of
adults treated with OVA and whether there is a sex bias in the responses are the subjects of the
present investigation.
Just as sex differences in response to irritants exist among human asthma patients
(Tantisira et al. 2008), studies in animal models have revealed some sex differences in lung
responses, particularly those associated with AHR. Male C57BL/6 mice are innately more
responsive than females to aerosolized methacholine (Card et al. 2006). In BALB/c mice,
however, females were reported to be more responsive than males after OVA challenge (Melgert
et al. 2005). Whether sex-associated differences also exist among OVA-challenged mice that

2

Reprinted with permission of the American Thoracic Society. Copyright © 2014 American
Thoracic Society. Xiao R, Perveen Z, Rouse RL, Le Donne V, Paulsen DB, Ambalavanan N,
Penn AL. In utero exposure to second-hand smoke aggravates the response to ovalbumin in
adult mice. Am J Respir Cell Mol Biol 2013 Dec;49(6):1102-1109.
Official Journal of the American Thoracic Society.
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have been exposed in utero to SHS has not been investigated rigorously. An earlier study in our
laboratory showed that in utero SHS exposure mildly aggravated asthma-associated lung
responses to OVA exposure in 15-week-old female BALB/c mice (Penn et al. 2007). We
designed the present study to:
 Test whether the effects of in utero SHS exposure were sustained in older mice
exposed to OVA;
 Examine in greater detail than previously determined (Penn et al. 2007) the range and
extent of responses to in utero SHS-adult OVA exposure;
 Determine whether sex differences exist in responses of mice to SHS-OVA.
We exposed pregnant BALB/c mice to HEPA-filtered air (AIR) or to SHS diluted with
AIR daily from gestation days 6-19 and exposed all offspring to an OVA sensitization/challenge
protocol from 19-23 weeks of age. We assessed the following outcomes: pulmonary function
(AHR, breathing frequency), lung histopathology (inflammation, structural changes),
bronchoalveolar lavage fluid (BALF) cytokine levels and lung gene expression patterns,
primarily the identification of SHS-related gene pathways.

3.2 Materials and Methods
Animal protocols, SHS and OVA exposures. We conducted SHS exposures on
BALB/c mice (Harlan, Indianapolis, IN), as described previously (Penn et al. 2007; Xiao et al.
2012). Briefly, half of the mated females, randomly-selected, were exposed to SHS generated
from 3R4F filtered research cigarettes (University of Kentucky; 10 mg/m3) mixed with AIR
daily, from days 6-19 of gestation. The remaining mated females received 100% AIR exposures
instead. All offspring were sensitized by injections of OVA (Grade V >98% pure, SigmaAldrich, St. Louis, MO; 80 µg in 2 ml alum) at 19 & 21 weeks of age, followed by OVA aerosol
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challenge every other day in weeks 22 & 23, before sacrifice. Mice were classified in one of
four groups, depending on in utero exposure to SHS (S) or AIR (A), and their sex. All offspring
were exposed to OVA. The numbers of animals in each group assessed in each assay are listed
with each figure. Mice were housed and handled in accord with the NIH Guide for the Care and
Use of Laboratory Animals. All procedures and protocols were approved by the LSU
Institutional Animal Care and Use Committee. The group designation and exposure timeline are
presented in Figure 3-1.

Figure 3–1. Group designation and exposure timeline of the SHS-OVA study. The three-letter
symbols were assigned to four experimental groups, depending on the exposure period in utero
and adult, plus sex of the mice. Times shown in the exposure timeline are expressed relative to
birthdate of offspring. GD, gestation day.
Pulmonary function testing. This was carried out as described previously (Penn et al.
2007; Xiao et al. 2012). For each mouse at each methacholine dose level (3-50 mg/ml), readings
over 5 minutes were averaged for Penh and breathing frequency. Penh values represent the
degree of AHR in each animal.
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Histopathologic analysis of lungs. We followed previously published procedures (Penn
et al. 2007; Xiao et al. 2012) for BALF collection, fixation, sectioning, staining and scoring of
3-4 µm lung sections, and for lung morphometric analysis (Xiao et al. 2012). Goblet cells and
mucin were stained with the routine Periodic acid-Schiff (PAS) stain on 5 µm, paraffinembedded tissue sections from the same blocks as were used in the H&E stains. 12 males each
from the treatment and control groups were evaluated. Slides were scored for estimated percent
of linear mucosa that was occupied by goblet cells and given the following scores: 0 for less
than 10%, 1 for 10% to 33%, 2 for 34% to 67%, and 3 for greater than 67%. Additionally, lungs
were evaluated for the presence (+) or absence (-) of goblet cells in the distal 2 generations of
bronchioles in the peripheral lung.
Cytokine quantitation in BALF. Mouse Th1/Th2 9-plex kits (MSD, Meso Scale
Discovery, Gaithersburg, MD) & ELISA plates for IL-13 were used to measure 10 major
Th1/Th2 cytokines (IFN-γ, IL-1b, IL-2, IL-4, IL-5, IL-10, IL-12, IL-13, KC/CXCL1, TNF-α) in
BALF.
Statistical analysis. We used the SAS statistical package (version 9.3; SAS Institute,
Inc., Cary, NC) for data analyses. We performed one-way ANOVA and post hoc Tukey’s HSD
(honest significant difference) test for multiple pairwise-comparisons, including SHS-OVA
versus AIR-OVA responses in males and females (*) as well as SHS-OVA responses in males
versus females (†). Statistical differences between SHS-OVA and AIR-OVA with pooled M and
F responses (‡) were calculated by a t-test. In all cases, we considered comparisons significant at
P<0.05. Error bar indicates mean ± SEM.
Lung harvest and mRNA extraction. We followed previously described procedures
(Penn et al. 2007; Xiao et al. 2012), including RNA sample quantity and purity assessment with
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a NanoDrop ND-1000 Spectrophotometer (NanoDrop, Wilmington, DE), and further assayed
1:5 dilutions of RNA samples with an Agilent 2100 BioAnalyzer and Agilent RNA 6000 Nano
Series II Kits (Agilent Technologies, Palo Alto, CA). All samples fell into the following ranges:
260/280 ratio: 2.14-2.19; 260/230 ratio: 1.91-2.34; concentration: 970-2845 ng/μl; 28S/18S ratio:
1.6-2.0, RNA integrity number: 9.2-10.0.
Microarray analysis and Ingenuity Pathway Analysis (IPA). We assessed global gene
expression in lungs of individual 23-week old mice (4 mice per group) on mouse 430.2 genome
arrays (Affymetrix, Santa Clara, CA). The arrays were processed at the Research Core Facility
of Louisiana State University Health Science Center-Shreveport. We performed two pairwisecomparisons on “SOF versus AOF” and “SOM versus AOM” with the limma package (Smyth
2004) in the R/bioconductor platform (www.r-project.org; www.bioconductor.org). Gene probes
with at least 2-fold up/down-regulation and FDR<0.05 were considered differentially expressed.
The microarray data have been deposited in NCBIs Gene Expression Omnibus (GEO, accession
number GSE38409). We performed gene-set functional analyses and generated gene networks
with IPA (Ingenuity Systems, Redwood City, CA; www.ingenuity.com).
qRT-PCR. Total RNA was reverse-transcribed with the High Capacity cDNA reverse
transcription kit (Applied Biosystems, Foster City, CA). Expression levels of selected genes
were measured with TaqMan universal PCR master mix (Applied Biosystems) and predesigned
Taqman probes for mouse genes (assay ID: Hprt1, Mm00446968_m1; Cxcl2, Mm00436450_m1;
Cxcl5,

Mm00436451_g1;

Ccl8,

Mm01297183_m1;

Ccl24,

Mm00444701_m1;

Il1b,

Mm00434228_m1; Il6, Mm00446190_m1; Il13, Mm00434204_m1; Il17b, Mm01258783_m1;
Saa1, Mm00656927_g1; Saa3, Mm00441203_m1; Timp1, Mm00441818_m1). The gene
expression levels were normalized to Hprt1 levels.
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3.3 Results
Pulmonary function testing. Pulmonary function testing revealed significantly
increased AHR and decreased breathing frequency in the male and female SHS-OVA groups
following methacholine challenge, compared to those in AIR-OVA groups. Among all mice
exposed in utero to SHS, male offspring exhibited significantly aggravated AHR compared with
SHS-exposed females at methacholine doses 3-12 mg/ml (Figure 3-2).

Figure 3–2. The SHS-OVA groups exhibited significantly increased AHR and decreased
breathing frequency. Whole-body plethysmography revealed significantly increased AHR (Penh)
and decreased breathing frequency (f) in SHS-OVA mice, compared with all mice from AIROVA groups [i.e., when we pooled data for females plus males in each exposure set (‡)]. In
addition, there was significantly increased AHR in SOM versus all other groups especially at low
methacholine doses (†, SOM versus SOF). ‡ (SO vs AO, female and male pooled) @ 6,50 for
AHR, @ 25 for f. † (SOM vs SOF, sex difference) @ 3,6,12 for AHR.
Inflammatory cells. Eosinophil counts in BALF were high for all 4 groups. Significant
differences were found between SHS-OVA and AIR-OVA for eosinophils and neutrophils.
There was a pronounced lung inflammatory response in all four groups (Figure 3-3). The high
levels of inflammation made it difficult to reliably quantitate the mean linear intercept and radial
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alveolar count values, which we have used previously to assess lung structural changes (Xiao et
al. 2012).

Figure 3–3. There were significantly increased numbers of eosinophils and neutrophils in the
SHS-OVA groups. The eosinophil is the major cell type found in BALF for all groups (left panel).
There were significantly increased eosinophils and neutrophils in the SHS-OVA groups compared
the AIR-OVA groups (‡). Significant differences within either sex (SOF versus AOF & SOM
versus AOM) were also found for eosinophils (*). Lung histology of all 4 groups revealed severe
inflammation with accumulated inflammatory cells in the airways around bronchioles (right
panel). Airspaces in the alveolar region are occupied by inflammatory cells that are stained dark
blue. Bar=50 µm.
We also evaluated percent linear mucosa occupied by goblet cells and presence/absence
of goblet cells in the distal 2 generations of bronchioles in the peripheral lung. A board-certified
veterinary pathologist, blinded to the treatments, evaluated histopathologic samples and found
no differences for either set of measurements between males and females or between SHS- and
AIR-exposed mice, as shown in Table 3-1.
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Table 3–1. There were no significant differences between SHS- and AIR-exposed mice, regarding
percent linear mucosa occupied by goblet cells and presence/absence of goblet cells, in the distal
2 generations of bronchioles in the peripheral lung.
Slide

Group

goblet cells, bronchi
[0 (none) -3 (numerous)]

goblet cells in distal
bronchioles (Y/N)

237B
239W
237A
239V
237E
239U
237F
239S
237G
239R
237I
239J
237J
239H
237M
239G
237N
239E
237O
239D
237Q
239C
237S
238S

SOM
AOM
SOM
AOM
SOM
AOM
SOM
AOM
SOM
AOM
SOM
AOM
SOM
AOM
SOM
AOM
SOM
AOM
SOM
AOM
SOM
AOM
SOM
AOM

3
2
3
3
2
3
2
1
2
3
3
3
2
2
2
3
2
2
3
2
2
2
3
3

Y
Y
N
Y
N
N
N
N
Y
Y
N
N
N
N
N
N
Y
N
N
N
N
Y
Y
N

BALF cytokines. We found significantly elevated cytokine levels in SHS-OVA versus
AIR-OVA for 8 of the 10 BALF Th1/Th2 cytokines we assessed (both sexes pooled, Figure 3-4):
IFN-γ, IL-1b, IL-4, IL-5, IL-10, IL-13, KC/CXCL1 and TNF-α. IL-2 and IL-12 also were
detected but were not significantly different between AIR-OVA and SHS-OVA groups (data not
shown). The post-hoc Tukey’s test among all 4 groups further confirmed the significant
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differences between males (SOM versus AOM) for all 8 cytokines and between females (SOF
versus AOF) for 5 cytokines (IL-1b, IL-4, IL-5, IL-13, KC/CXCL1). Cytokine levels in BALF
from the male SHS-OVA offspring were even higher than corresponding levels in SHS-OVA
females and significant differences were found for IFN-γ, IL-1b, IL-5, IL-10 and KC/CXCL1.

Figure 3–4. BALF cytokines were significantly increased in the SHS-OVA groups. BALF
cytokine levels determined by ELISA for the 8 cytokines listed, were increased significantly in
SHS-OVA groups compared with AIR-OVA groups (‡). This was also true for all 8 cytokine
comparisons between the males (*, ♂, SOM versus AOM) and 6 out of 8 cytokines for females (*,
♀, SOF versus AOF). In the cases of IFN-γ, IL-1b, IL-5, IL-10 and TNF-α, we found significantly
elevated responses in the males compared with the females for mice exposed in utero to SHS (†,
SOM versus SOF). Units on y-axes are pg/ml. ‡: all 8 (SOvsAO); †: 5/8 (SOMvsSOF); *: ♀ 6/8,
♂ 8/8.
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Gene expression profiling. With the differential expression threshold for genes in lung
homogenates set to a fold change of 2 and FDR<0.05, 65 genes in the females and 86 in the
males were differentially expressed between SHS-OVA and AIR-OVA mice (Online
Supplement), while 38 genes were shared by both sexes (Figure 3-5A, Table 3-2).
Table 3–2. All 113 differentially expressed genes between SHS-OVA and AIR-OVA groups,
shown in Figure 3-5A, are listed with additional information.
Gene
Symbol
Cxcl5
Ddx4
Cxcl3
Sprr2a
Aldh1a3
Timp1
Saa3
Cxcl13
Sprr2a
Ccl24
Chl1
Cxcl13
Fxyd4
4833422F2
4Rik
Arg1
Tnfrsf9
Cxcl2
Reg3g
Il6
Serpina3n
Cxcl1
Selp
Saa1
Cxcl1
Ch25h
Ccl7
Cd177
Birc5
Cd163
Retnlb
Ppil5
Ccnb1

SOF versus AOF
P.Value

FDR

Fold
Change

6.8E-06
1.8E-03
8.9E-10
2.1E-03
1.6E-06
3.2E-06
4.4E-04
1.6E-02
2.3E-03
1.6E-03
5.1E-04
1.9E-02
2.2E-04

7.1E-03
8.8E-02
4.0E-05
9.6E-02
4.5E-03
5.2E-03
4.7E-02
2.3E-01
1.0E-01
8.2E-02
5.0E-02
2.5E-01
3.2E-02

5.36
8.31
10.72
4.12
2.53
4.38
3.70
2.69
3.48
4.97
2.11
2.14
2.95

3.5E-04

4.1E-02

5.14

6.6E-04
2.8E-04
8.1E-07
6.3E-01
2.5E-03
5.5E-09
1.3E-05
9.8E-04
1.0E-05
3.8E-04
1.3E-06
2.6E-04
3.0E-02
3.1E-06
1.2E-03
1.4E-02
3.0E-07
4.3E-06

5.6E-02
3.7E-02
4.5E-03
8.8E-01
1.0E-01
1.2E-04
8.5E-03
6.6E-02
8.1E-03
4.3E-02
4.5E-03
3.5E-02
3.0E-01
5.2E-03
7.2E-02
2.2E-01
3.4E-03
5.9E-03

6.27
2.65
3.18
1.16
2.22
2.78
2.75
1.51
2.23
2.15
3.35
1.90
1.93
2.59
1.84
1.88
2.64
2.33

SOM versus AOM
Affymetrix_ID

♀

P.Value

FDR

Fold
Change

♂

*

*

2.5E-06
5.7E-04
4.4E-05
7.6E-08
1.4E-08
4.2E-09
9.4E-09
1.8E-06
3.0E-07
8.3E-05
8.9E-06
7.4E-07
8.2E-07

1.6E-03
2.1E-02
5.5E-03
3.8E-04
1.6E-04
1.4E-04
1.4E-04
1.5E-03
6.3E-04
7.9E-03
2.6E-03
9.7E-04
9.7E-04

8.64
7.89
5.66
5.52
5.40
5.38
5.19
4.73
4.33
4.25
3.91
3.84
3.74

*
*
*
*
*
*
*
*
*
*
*
*
*

1419728_at
1427242_at
1438148_at
1450618_a_at
1448789_at
1460227_at
1450826_a_at
1417851_at
1439016_x_at
1450488_at
1435190_at
1448859_at
1418207_at

*

8.2E-06

2.5E-03

3.67

*

1425386_at

8.9E-05
1.1E-05
2.1E-04
6.0E-04
2.5E-07
1.2E-07
4.2E-04
3.4E-05
9.0E-09
5.1E-04
2.5E-08
4.8E-07
1.3E-05
1.3E-07
7.9E-08
6.4E-07
6.0E-05
5.6E-06

8.1E-03
2.7E-03
1.2E-02
2.1E-02
6.2E-04
4.1E-04
1.8E-02
4.8E-03
1.4E-04
1.9E-02
2.1E-04
8.0E-04
2.9E-03
4.2E-04
3.8E-04
9.7E-04
6.4E-03
2.1E-03

3.54
3.43
3.41
3.39
3.19
3.14
3.11
2.95
2.85
2.78
2.76
2.76
2.72
2.70
2.65
2.62
2.56
2.53

*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*

1419549_at
1428034_a_at
1449984_at
1448872_at
1450297_at
1419100_at
1419209_at
1440173_x_at
1450788_at
1457644_s_at
1449227_at
1421228_at
1424509_at
1424278_a_at
1419144_at
1418368_at
1452458_s_at
1416076_at

*
*
*
*

*
*

*
*
*
*
*

*

*
*
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(Table 3–2 continued)
Gene
Symbol
Rrm2
Rrm2
Cdca5
Il4i1
Rrm2
Myom2
Orm1
Cd209e
Hist1h2ab
Ear11
Ube2c
Selp
Vcan
Il13ra2
LOC632073
Fbp1
Pdcd1lg2
Ccnb1
Afp
Cdca8
Saa1
Guca2a
Shcbp1
Cdca8
Cdca8
Gpr109a
Ckmt2
Aurkb
Cenpe
U46068
Cdc6
Ccl17
Il1r2
Ccl2
Uhrf1
Aurkb
Top2a
Cep55
Sprr2a
Kif11
Ncapg
Selp
Bub1
Muc4

SOF versus AOF
Fold
P.Value
FDR
Change
5.4E-07
1.7E-06
3.5E-07
2.2E-03
5.7E-06
3.4E-01
1.4E-02
6.2E-04
3.1E-05
1.0E-04
1.3E-05
1.3E-04
4.9E-04
8.1E-04
3.8E-01
1.6E-01
1.1E-03
2.8E-06
9.8E-07
1.0E-05
5.9E-05
7.4E-04
5.7E-06
1.2E-04
2.9E-06
2.1E-03
9.7E-01
3.4E-04
1.5E-03
4.2E-01
7.3E-06
4.4E-03
7.7E-04
3.4E-03
5.3E-05
9.2E-06
6.4E-06
3.1E-05
2.7E-03
1.6E-06
1.8E-06
1.8E-06
2.7E-06
9.5E-03

3.5E-03
4.5E-03
3.4E-03
9.9E-02
6.3E-03
7.2E-01
2.2E-01
5.4E-02
1.2E-02
2.2E-02
8.5E-03
2.4E-02
4.9E-02
6.1E-02
7.4E-01
5.5E-01
6.8E-02
5.2E-03
4.5E-03
8.1E-03
1.7E-02
5.8E-02
6.3E-03
2.4E-02
5.2E-03
9.5E-02
9.9E-01
4.1E-02
8.1E-02
7.7E-01
7.3E-03
1.3E-01
5.9E-02
1.2E-01
1.7E-02
7.7E-03
6.9E-03
1.2E-02
1.1E-01
4.5E-03
4.5E-03
4.5E-03
5.2E-03
1.9E-01

2.70
2.72
2.75
2.31
2.75
1.27
1.50
1.81
2.18
2.40
2.54
1.71
1.68
1.75
1.18
1.42
2.72
2.06
2.09
2.41
2.24
2.48
2.49
1.71
2.02
1.47
1.01
1.92
2.01
1.18
2.16
1.65
1.67
1.65
1.82
1.99
2.34
2.47
1.82
2.46
2.67
1.73
2.27
1.29

♀
*
*
*
*

*
*
*

*
*
*
*
*
*

*

*
*
*
*
*

SOM versus AOM
Fold
P.Value
FDR
Change
3.0E-06
6.4E-06
7.4E-06
5.9E-06
9.2E-06
7.0E-04
1.6E-04
4.1E-06
8.8E-06
7.8E-06
3.0E-05
5.1E-08
5.1E-06
6.1E-05
1.3E-03
1.5E-04
2.7E-06
3.7E-05
1.4E-06
4.5E-06
9.5E-05
6.3E-05
3.1E-06
9.2E-06
3.3E-06
2.0E-07
2.1E-03
6.7E-05
3.8E-05
1.3E-03
3.1E-07
1.5E-03
2.5E-06
2.6E-04
2.8E-08
2.4E-05
5.1E-06
8.2E-07
5.9E-05
1.6E-05
5.4E-05
9.6E-07
4.7E-06
7.9E-05
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1.7E-03
2.1E-03
2.3E-03
2.1E-03
2.6E-03
2.3E-02
1.1E-02
1.9E-03
2.6E-03
2.4E-03
4.6E-03
3.3E-04
2.1E-03
6.5E-03
3.2E-02
1.0E-02
1.7E-03
5.0E-03
1.3E-03
2.0E-03
8.3E-03
6.7E-03
1.8E-03
2.6E-03
1.8E-03
5.3E-04
4.1E-02
6.9E-03
5.1E-03
3.2E-02
6.3E-04
3.4E-02
1.6E-03
1.4E-02
2.1E-04
4.0E-03
2.1E-03
9.7E-04
6.4E-03
3.2E-03
6.1E-03
1.0E-03
2.0E-03
7.6E-03

2.52
2.50
2.46
2.46
2.44
2.36
2.34
2.32
2.31
2.30
2.29
2.26
2.24
2.24
2.23
2.23
2.22
2.22
2.21
2.20
2.20
2.19
2.18
2.18
2.17
2.17
2.16
2.15
2.15
2.15
2.14
2.13
2.11
2.09
2.09
2.08
2.07
2.06
2.06
2.04
2.04
2.03
2.02
2.02

♂
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*

Affymetrix_ID

1434437_x_at
1448226_at
1416802_a_at
1419192_at
1416120_at
1457435_x_at
1451054_at
1420582_at
1438009_at
1425295_at
1452954_at
1449906_at
1421694_a_at
1422177_at
1423719_at
1448470_at
1450290_at
1419943_s_at
1416645_a_at
1436847_s_at
1419075_s_at
1416905_at
1416299_at
1428480_at
1428481_s_at
1419721_at
1428722_at
1424128_x_at
1439040_at
1439423_x_at
1417019_a_at
1419413_at
1419532_at
1420380_at
1415810_at
1451246_s_at
1454694_a_at
1452242_at
1437258_at
1435306_a_at
1429171_a_at
1420558_at
1424046_at
1427398_at

(Table 3–2 continued)
Gene
Symbol
Ccnb1
Cdc2a
Mki67
Ccna2
Ncapg
Ccna2
Cdca3
2810417H1
3Rik
Rad51
Ttk
Nusap1
Esco2
Cks1b
Hells
Nuf2
Cyp26b1
Cenpp
Aspm
Slc7a2
Kif11
Slc7a2
Kif20a
C330027C0
9Rik
Tpx2
Cep55
Egr2
--G530011O0
6Rik
Pon1
C1qtnf3
Fmo3
Esm1
Itgbl1
Fabp7
Gpnmb
Bex1
Igh /// Ighg

SOF versus AOF
Fold
P.Value
FDR
Change

♀

SOM versus AOM
Fold
P.Value
FDR
Change

♂

1.2E-05
4.1E-05
5.3E-06
2.4E-05
2.8E-04
7.2E-05
2.3E-06

8.4E-03
1.5E-02
6.3E-03
1.1E-02
3.7E-02
1.9E-02
5.1E-03

2.23
2.17
2.46
2.18
2.07
2.11
2.12

*
*
*
*
*
*
*

2.2E-05
1.1E-05
6.4E-05
6.7E-05
1.8E-04
1.5E-05
2.1E-05

3.9E-03
2.7E-03
6.7E-03
6.9E-03
1.1E-02
3.2E-03
3.7E-03

2.00
1.99
1.97
1.95
1.94
1.93
1.90

2.4E-05

1.1E-02

2.18

*

1.2E-05

2.8E-03

1.90

1419153_at

1.2E-05
4.1E-05
2.9E-05
4.7E-07
4.3E-05
5.6E-05
6.9E-05
2.1E-04
1.6E-04
1.7E-05
4.3E-05
4.9E-05
1.8E-04
2.2E-06

8.4E-03
1.5E-02
1.2E-02
3.5E-03
1.5E-02
1.7E-02
1.9E-02
3.1E-02
2.7E-02
9.0E-03
1.5E-02
1.6E-02
2.9E-02
5.1E-03

2.30
2.01
2.28
2.30
2.05
2.11
2.16
3.10
2.07
2.03
2.21
2.19
2.11
2.04

*
*
*
*
*
*
*
*
*
*
*
*
*
*

6.2E-06
3.2E-04
2.8E-06
1.6E-05
1.0E-05
9.4E-07
1.0E-04
2.6E-01
7.2E-04
3.7E-05
6.0E-06
2.6E-04
1.0E-06
1.1E-03

2.1E-03
1.6E-02
1.7E-03
3.2E-03
2.7E-03
1.0E-03
8.6E-03
5.4E-01
2.3E-02
5.0E-03
2.1E-03
1.4E-02
1.0E-03
2.9E-02

1.89
1.89
1.86
1.84
1.84
1.80
1.76
1.76
1.74
1.73
1.71
1.60
1.60
1.54

1418281_at
1449171_at
1416309_at
1428304_at
1416698_a_at
1417541_at
1430811_a_at
1460011_at
1432361_a_at
1422814_at
1426008_a_at
1452314_at
1422648_at
1449207_a_at

1.3E-05

8.5E-03

2.20

*

6.8E-04

2.3E-02

1.51

1449699_s_at

2.0E-05
9.7E-05
8.4E-05
1.5E-06

9.8E-03
2.2E-02
2.0E-02
4.5E-03

2.12
2.00
2.17
-2.47

*
*
*
*

1.1E-05
3.1E-04
4.4E-03
6.4E-02

2.7E-03
1.5E-02
6.1E-02
2.6E-01

1.50
1.48
1.35
-1.20

1428104_at
1453683_a_at
1427682_a_at
1445238_at

1.2E-05

8.4E-03

2.10

*

2.0E-01

4.7E-01

-1.28

1440342_at

8.0E-04
1.4E-03
3.2E-04
2.2E-03
3.5E-04
1.8E-01
4.4E-01
3.0E-01
6.2E-01

6.1E-02
7.7E-02
4.0E-02
9.8E-02
4.1E-02
5.8E-01
7.8E-01
6.8E-01
8.7E-01

-2.01
-1.76
-2.36
-2.52
-1.60
-1.22
-1.24
-1.21
1.42

4.8E-04
2.3E-04
3.2E-05
1.0E-04
1.1E-07
1.9E-06
2.4E-05
2.7E-05
1.0E-03

1.9E-02
1.3E-02
4.7E-03
8.5E-03
4.1E-04
1.5E-03
4.0E-03
4.3E-03
2.8E-02

-2.10
-2.14
-2.16
-2.32
-2.49
-2.68
-3.06
-3.64
-4.24

*
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*

Affymetrix_ID

*
*
*
*
*
*
*
*
*

1448205_at
1448314_at
1426817_at
1417911_at
1429172_a_at
1417910_at
1452040_a_at

1418190_at
1422606_at
1449525_at
1449280_at
1425039_at
1450779_at
1448303_at
1448595_a_at
1451632_a_at

Figure 3–5. Differentially expressed genes were identified for SOF vs AOF and SOM vs AOM. A.
Venn diagram shows numbers of differentially expressed genes in two pairwise comparisons. B.
Transcriptome screening revealed differentially expressed genes by comparing SHS-OVA and
AIR-OVA responses in mice of each sex. We plotted each gene’s Log2Ratios from “SOF versus
AOF” and “SOM versus AOM” onto the x-axis and y-axis respectively. The “y=x” line indicates
the same degree of expression changes in both females and males. All gene symbols shown are
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differentially expressed in either male or female mice (|fold change|≥2, FDR< 0.05; N=4 mice in
each group). C. Magnified view of box outlined in panel B.
Although the ranges of fold change values are similar for both sexes (Fold change: ↓4.0 ↑11.3, Log2Ratio: -2.0 - +3.5, Figure 3-5B), not only were there more differentially expressed
genes for males than for females (86 versus 65), the majority of the 38 shared genes exhibited
higher fold change values in the males than the females (Figures 3-5 & 3-6). This indicated that,
on a transcriptional level, males are more responsive than females to OVA as adults after in
utero exposure to SHS.
This is also evident from Figure 3-5C (in magnified view, Log2Ratios within 0.5 - 2.5
range), where there are more genes located above the “y=x” line that delineates the same degree
of up-regulation in both males and females. A few down-regulated genes also were identified,
including β1-integrin (Itgb1, ♀: ↓1.60; ♂: ↓2.49) and paraoxonase (Pon1, ♀: ↓2.01; ♂: ↓2.10).
We used IPA to illuminate biological responses and signaling pathways consistent with
in utero SHS-associated gene expression changes in adult mouse lungs. We focused on the 113
differentially expressed genes found in either or both sexes (Figure 3-5A, 27+38+48=113). We
found the most statistically significant diseases and disorders pathways to be “Inflammatory
Response”, “Cancer” and “Respiratory Disease” (P-value≤7.05E-03). The IL-17 signaling
pathways (P-value≤8.32E-04) were among the most significant canonical signaling pathways.
The IPA results are listed in Table 3-3.
We found significant differences by qRT-PCR (Figure 3-6) between SHS-OVA and
AIR-OVA for all 11 genes initially identified by BALF cytokine assessment (ELISA) or by
microarray analysis. For each of the 11 genes, relative expression levels were significantly
higher for SOF versus AOF and for SOM versus AOM. These 11 genes include chemokines
(Ccl8, Ccl24, Cxcl2, Cxcl5), cytokines (Il1b, Il6, Il13, Il17b) and acute phase response genes
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(Saa1, Saa3) associated with inflammatory responses. In addition, for 3 of the 11 genes (Il1b, Il6
and Timp1), there were significantly increased expression levels in SOM versus SOF. The
ΔΔCT values (compared to the house-keeping gene Hprt1) are charted in Figure 3-6. A ΔΔCT
difference of one represents a 2-fold difference in expression.
Table 3–3. Ingenuity Pathway Analysis results indicated that the differentially expressed genes
affected by in utero SHS exposure are significantly associated with inflammatory responses,
cancer and respiratory disease, and also are involved in IL-17-associated pathways.
Diseases and Disorders
Inflammatory Response
Cancer
Respiratory Disease
Dermatological Diseases and Conditions
Immunological Disease

P-value
2.85E-08 - 7.05E-03
7.69E-08 - 7.05E-03
2.12E-07 - 6.99E-03
5.19E-07 - 7.05E-03
5.90E-07 - 7.05E-03

# Molecules
29
52
29
27
26

Canonical Pathways
Role of IL-17A in Psoriasis
LXR/RXR Activation
Role of IL-17F in Allergic Inflammatory
Airway Diseases
Role of IL-17A in Arthritis
IL-17A Signaling in Airway Cells

P-value
3.92E-05
1.29E-04
1.57E-04

Ratio*
3/13 (0.231)
6/136 (0.044)
4/48 (0.083)

4.47E-04
8.32E-04

4/63 (0.063)
4/72 (0.056)

Ratio*: Denominator = total # of genes in the pathway; Numerator = # of pathway genes
identified in our studies.
We then created a gene network in IPA Pathway Designer, by combining the most
differentially expressed genes with the most significant biological functions and canonical
pathways, according to the Ingenuity Knowledge Base. These functions and pathways were
directly associated with inflammatory responses, AHR, acute phase response signaling and IL17 signaling (Figure 3-7). The network indicated key information about the gene of interest,
including degree of up/down-regulation for either sex (for the two bars in the brackets: females
on the left, males on the right), fold change values in males, and each gene’s functional
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association. With very few exceptions, the left-hand bar (female) is shorter than the right-hand
bar (male), further supporting the conclusion that males are more sensitive than females in this
SHS-OVA model.

Figure 3–6. Differentially expressed genes identified by BALF cytokine or microarray were
confirmed by qRT-PCR. qRT-PCR confirmed 11 differentially expressed genes identified by
BALF cytokine assessment or microarray analysis. The y-axis is –ΔΔCT, so the higher the value,
the higher the expression level for each group. The line “y=0” represents the level of housekeeping gene (Hprt1) expression. Since the y-axis is calculated from cycle number differences, a
difference of one on the y-axis = a 2-fold difference in expression. Beneath each gene symbol, the
fold change differences between SHS-OVA and AIR-OVA in either sex are shown, together with
asterisks to indicate statistical differences (P<0.05). We carried out qRT-PCR in each of the 4
groups (6 mice/group) except for Ccl24 (N≥5) and Timp1 (N≥4). ‡: all 11 (SOvsAO); †: 3/11
(SOMvsAOF); *: ♀ 10/11, ♂ 10/11.
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Figure 3–7. Ingenuity Pathway Analysis of microarray results identified biological functions and
canonical pathways associated with in utero SHS exposure. Ingenuity pathway analysis on
microarray results identified several significant biological functions (“Fx:”) and canonical
pathways (“CP:”) associated with in utero exposure to SHS in either sex. The color intensity
inside each gene symbol and in the right-hand bar inside each bracket is associated with relative
fold changes between SOM versus AOM (more saturated red = higher degree of up-regulation).
The left-hand bar represents relative level of gene up-regulation in SOF versus AOF. Gene
abbreviations: Arg1, arginase (liver); Ear11, eosinophil-associated ribonuclease 11; Retnlb,
resistin like beta; Saa 1/3, serum amyloid A; Selp, selectin (platelet); Serpina3n, serine (or
cysteine) peptidase inhibitor, clade A, member 3N; Slc7a2, solute carrier family 7 member 2;
Timp1, tissue inhibitor of metalloproteinase 1; Top2a, DNA topoisomerase 2-alpha; Vcan,
versican.
3.4 Discussion
This study was designed to investigate the effects of in utero SHS exposure and of sex
differences on adult responses of mice under identical OVA challenge conditions in a mouse
asthma model. We used BALB/c mice for three reasons, i) BALB/c mice are a well-accepted
strain for asthma studies (Boyce and Austen 2005; Kips et al. 2003; Lloyd 2007; Nials and
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Uddin 2008; Temelkovski et al. 1998); ii) a high correlation has been reported for these mice
between Penh values and lung resistance (DeLorme and Moss 2002; Hamelmann et al. 1997;
Singh et al. 2003), iii) we have established laboratory protocols in BALB/c mice for
investigating the effects of in utero SHS exposure on adult lung responses to environmental
irritants (Penn et al. 2007; Xiao et al. 2012). Control groups without OVA challenge were not
included in the study because our previous studies revealed that adult mice exposed in utero to
SHS, but not exposed as adults to environmental stressors, do not exhibit signs of inflammation
compared to the AIR mice (Penn et al. 2007; Xiao et al. 2012).
One consequence of having all groups of adult mice exposed to OVA was that the
resulting inflammation masked airway structural changes to which the in utero SHS exposure
undoubtedly contributed (Xiao et al. 2012). The large numbers of infiltrated inflammatory cells
present in the lungs of both male and female mice in all groups made accurate morphometric
assessment unachievable (Figure 3-3). In contrast, the results from lung function testing, BALF
analysis, and gene expression profiling all demonstrated that in utero SHS exposures aggravate
responses to adult OVA exposures. In addition, results are more pronouced in male mice than in
females..
Lung function testing revealed that there was increased AHR and decreased breathing
frequency (f) in SHS-OVA mice, compared to AIR-OVA mice, regardless of sex, at multiple
methacholine doses. The males exposed to SHS in utero were more responsive than females
who were exposed similarly (Figure 3-2). These findings indicate that both SHS in utero and sex
differentially affect adult lung responses to inhaled environmental stressors.
The prominent lung responses of OVA-exposed adult males that had been exposed in
utero to SHS were supported by the elevated BALF cytokine levels (Figure 3-4). SHS exposure
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in utero markedly increased the levels both of pro-inflammatory cytokines (IFN-γ, IL-1b,
KC/CXCL1 and TNF-α) and of Th2 cytokines (IL-4, IL-5, IL-10 and IL-13). This is consistent
with the OVA-induced mouse model of asthma. The sex-associated differences described here
are associated with two other findings: i) the baseline BALF cytokine levels of male mice were
not significantly higher than females; on the contrary, for 6/8 cytokines--IFN-γ, IL-1b, IL-4, IL5, IL-10 and TNF-α-- female mice exhibited slightly higher baseline BALF cytokine levels than
the males, although the difference for each of the cytokines did not reach the level of statistical
significance; ii) male mice exposed in utero to SHS had much higher BALF cytokine levels than
the females.
Results from transcriptome screening supported the findings from lung function testing
and BALF cytokine measurements. We performed transcriptome screening on individual whole
lung homogenates collected from 4 mice/group for each of the 4 groups, and searched for the
differentially expressed genes between SHS-OVA and AIR-OVA in either sex. As shown in
Figure 3-5A, we found more differentially expressed genes for the males (N=86 genes, SOM
versus AOM) than for the females (N=65 genes, SOF versus AOF). Notably, a large portion of
the most differentially expressed genes were chemokines and cytokines involved in
inflammatory responses. With only a few exceptions, they exhibited a higher degree of upregulation in the males than in the females.
To study the biological functions and signaling pathways associated with these
differentially expressed genes identified by transcriptome screening, we performed several
analyses in IPA of the 113 genes we found differentially expressed in either males or females.
“Inflammatory response”, “cancer” and “respiratory disease” are the top 3 diseases/disorders
that are significantly associated with these genes. As shown in Figure 3-7, in addition to
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inflammation

pathways,

significantly

associated

pathways

include

“airway

hyperresponsiveness”, “acute phase response signaling” and “IL-17 signaling”. There is no
doubt that the OVA challenge triggers acute phase response signaling, causes severe
inflammation, and increases AHR. However, all mice received identical OVA exposures,
indicating that changes in gene expression were due to SHS exposure in utero and supporting in
utero SHS exposure as a potential factor in aggravated adult lung responses.
Despite the fact that most genes affected by in utero SHS were up-regulated on
microarrays, we identified a few down-regulated genes as well. These genes, including Itgb1
and Pon1, were consistent with data from some human studies. Β1-integrin (Itgb1, ♀: ↓1.60; ♂:
↓2.49), initially activated by P-selectin, has been reported to increase during early stages of
asthma but to diminish in subjects with severe asthma (Johansson et al. 2012). Pon1 (♀: ↓2.01;
♂: ↓2.10) is decreased in asthmatic versus non-asthmatic children (Cakmak et al. 2009). The
decreases in expression of Itgb1 and Pon1 found during asthma exacerbation suggest a
protective role for these genes against asthma progression. For instance, integrin α9β1,
suppresses exaggerated contraction of the airway smooth muscle through inhibition of IP3dependent pathways (C Chen et al. 2012). Pon1, on the other hand, may attenuate asthmatic
responses via its anti-oxidative properties (Tolgyesi et al. 2009). The down-regulation of these
genes resulting from in utero exposure to SHS would further impair the defenses against severe
asthma.
We observed increased production of Th2 cytokines both transcriptionally (whole lung)
and translationally (BALF). The Th2 cytokines, IL-4, IL-5 and IL-13, are believed to mediate
isotype switching of allergen-specific B cells into IgE production, promoting airway
eosinophilia and inducing AHR (Epstein 2006), the latter two of which were also observed in
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this study. Although Th2 responses and eosinophilic inflammation largely explained the
observed responses in our earlier study, here the slightly increased BALF neutrophil counts and
up-regulation of neutrophil surface antigen Cd177 (♀: ↑1.93; ♂: ↑2.72), suggested early signs of
airway neutrophilia in OVA-challenged adult mice that were exposed in utero to SHS. As
neutrophils accumulate in the airway, which is common in severe allergic asthma (Wang and
Wills-Karp 2011), the presence of both eosinophils and neutrophils in the airways have been
reported to be associated with lowest lung function, poorest asthma control, and increased
exacerbations of asthma patients (Hastie et al. 2010). Recent reports have suggested the possible
involvement of IL-17 in neutrophilic inflammation (Hellings et al. 2003; Suzuki et al. 2007;
Wilson et al. 2009). IL-17 can induce lung structural cells to secrete pro-inflammatory cytokines,
as was found here for TNF-α, IL-1b, IL-6, and chemokines, including CXCL1 (KC), CXCL2
and CXCL8, thereby attracting neutrophils (Laan et al. 1999). According to IPA, the IL-17
signaling pathway is closely associated with Il6, Cxcl3 and Timp1, all of which we found to be
significantly up-regulated on microarrays. Microarray analysis also revealed that IL-17B, among
all the cytokines in the IL-17 family, showed increased expression in the SHS-OVA groups. In
our previous study (Xiao et al. 2012) where we studied recurring SHS exposure to mice that had
been to SHS in utero, IL-17 signaling also was one of the most significant canonical pathways
associated with in utero exposure to SHS. Findings from both studies demonstrate that the IL-17
signaling pathway is persistently modulated by in utero SHS exposures, independent of the adult
irritant. In addition, Th2 cytokines, particularly IL-4 and IL-13, also affect macrophage
polarization and induce alternatively activated M2 macrophages (Mills et al. 2000). Although
clear evidence was not found for M2 macrophages in the lungs, we found elevated expression of
genes that are primarily expressed in M2 macrophages (Nair et al. 2006; Nguyen et al. 2005;
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Staples et al. 2012): Arg1 (♀: ↑6.27; ♂: ↑3.54), Ccl17 (♀: ↑1.65; ♂: ↑2.13) and Cd163 (♀:
↑1.84; ♂: ↑2.65). Thus, SHS exposure in utero appears to aggravate adult asthmatic responses
mediated by a variety of cell types, including eosinophils, neutrophils and macrophages.
The most highly-responsive group, SOM, is of particular interest. The sex bias we report
was not apparent unless mice were exposed to SHS in utero, which means a) the in utero
environment selectively modified the male offspring more significantly than the females and b)
the differential effects of in utero exposure are prolonged to at least 23 weeks of age. Sexspecific effects induced by smoke exposures in utero have been shown by other researchers as
well. In a study by Ng et al. (Ng et al. 2006), in utero exposure to mainstream cigarette smoke
significantly reduced cytotoxic T-lymphocyte activity in 5- and 10-week-old male offspring,
whereas the females were not affected. In another study, Murphy et al. (Murphy et al. 2012) reported
in utero cigarette smoke-related increases in DNA methylation of insulin-like growth factor 2,
which is more pronounced in the male offspring than the females. Epigenetic alterations induced
by in utero smoke exposures have been revealed (Breton et al. 2009; Guerrero-Preston et al.
2010), with the potential for these alterations to persist into adulthood and modulate adult
responses (Jirtle and Skinner 2007; Tang and Ho 2007). We are currently investigating the
epigenetic changes associated with SHS exposure in utero to gain more insights into adult
disease susceptibility.
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CHAPTER 4.
IN UTERO EXPOSURE TO SECOND-HAND SMOKE ACTIVATES ONCOGENIC
MICRORNAS IN OVALBUMIN-CHALLENGED ADULT MICE3
4.1 Introduction
MicroRNAs (miRNAs) are small non-coding RNAs (19-23 nt), that serve as endogenous
sequence-specific regulators of various biological processes. Dysregulation of miRNA
expression has been implicated in diverse diseases, including inflammatory lung disease
(Oglesby et al. 2010), cardiovascular disease (Small et al. 2010) and cancer (Chen et al. 2012;
Melo and Esteller 2011). In recent years, an increasing body of literature has reported
dysregulated miRNA expression profiles resulting from direct exposures to various
environmental pollutants, including metal-rich particulate matter (Bollati et al. 2010), diesel
exhaust particles (Jardim et al. 2009; Yamamoto et al. 2013) and tobacco smoke (Izzotti et al.
2009; Schembri et al. 2009). Among these studies, metal-rich particulate matter and diesel
exhaust particle exposures were reported to aggravate systemic oxidative stress and to upregulate expression of miRNAs, particularly of miR-21 (Bollati et al. 2010; Yamamoto et al.
2013); whereas cigarette smoke exposures, both in vitro (human primary bronchial epithelial
cells) and in vivo (rat lungs), down-regulate expression of miRNAs. Although the dysregulated
miRNA expression profiles were clearly detectable immediately after exposures to the
environmental pollutants ended, whether the influence of the pollutants on miRNA expression
remains long after the exposures end has not yet been fully investigated.
Uterine life is one of the most critical periods for developmental programming (Knopik
et al. 2012); thus, in utero environmental exposures would be expected to have profound

3
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influence not only on fetal growth, but on postnatal health and disease conditions as well
(Martino and Prescott 2011). Previously, we reported that in utero second-hand smoke (SHS)
exposure aggravates adult responses to subsequent post-natal exposures to environmental
irritants, including ovalbumin (OVA) (Rouse et al. 2007; Xiao et al. 2013) and SHS (Xiao et al.
2012). In the most recent studies (Xiao et al. 2013), where we challenged all adult mice with
OVA to induce allergic asthma, we found, in this murine model of asthma (Kips et al. 2003),
that the effects of in utero SHS exposure persisted into adulthood, further aggravated lung
inflammation, increased airway hyperresponsiveness (AHR) and altered gene expression
profiles. However, whether in utero SHS dysregulates miRNA expression profiles and further
modulates target gene expression in adult mice that have been challenged by OVA, remains to
be determined.
We used RNA sequencing (RNA-seq) technology to establish the complete expression
profiles of miRNAs and mRNAs in adult mouse lungs from 23-week old female and male
BALB/c mice, that had been exposed in utero to either SHS or filtered air (AIR), and then as
adults to OVA. We aimed to answer the following questions:
 Can we identify dysregulated miRNAs in lungs of OVA-challenged adult mice that
had been exposed in utero to SHS compared to those exposed to AIR? Are there any
sex differences in miRNA expression? Are these changes associated with previously
observed pro-asthmatic lung responses?
 Are there any connections between the in utero SHS dysregulated miRNAs and
mRNAs that may lead to better understanding of the regulatory mechanisms
underlying the sustained effect of in utero SHS exposure?
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 Can we identify a miRNA-mRNA regulatory network that may contribute to
aggravated asthmatic responses or to other lung diseases?

4.2 Materials and Methods
Animal protocols, SHS and OVA exposures. The RNA samples originated from a
previous report (Xiao et al. 2013). Briefly, pregnant BALB/c mice (Harlan, Indianapolis, IN)
were exposed 5 hours per day on days 6-19 of pregnancy to SHS (3R4F filtered research
cigarettes, University of Kentucky; 10 mg/m3) mixed with HEPA-filted air (AIR) or AIR alone.
All offspring (females and males) were sensitized by OVA (Grade V >98% pure, Sigma-Aldrich,
St. Louis, MO; 80 µg in 2 ml alum) injections at 19 & 21 weeks of age, followed by OVA
aerosol challenge every other day in weeks 22 & 23, before sacrifice. Mice were divided into 4
groups: AOF, AOM, SOF and SOM, according to exposures in utero (A, S) and as adults (O),
plus sex (F, M). The 4 individual RNA samples with the highest RIN (RNA Integrity Number)
values in each group (collected from 4 different mice, N=4) were selected for RNA-seq analysis.
The experimental design is shown in Table 4-1.
Table 4–1. In utero exposure to SHS potentiates AHR, elevated BALF cytokine production and
altered lung gene expression in OVA-challenged adult mice.
In Utero
(GD 6-19)

Adult
(19-23wk)

Sex

Symbol

AHR

BALF
Cytokine

Lung Gene
Expression

AIR

OVA

Female

AOF

_

_

_

AIR

OVA

Male

AOM

_

_

_

SHS

OVA

Female

SOF

♀

↑

↑

↑

SHS

OVA

Male

SOM

♂

↑↑

↑↑

↑↑

=>

AHR: airway hyperresponsiveness; BALF: bronchoalveolar lavage fluid; GD: gestational day;
AIR: HEPA-filted air; SHS: second-hand smoke; ♀: SOF versus AOF; ♂: SOM versus AOM.
Data summarized from a previous publication (Xiao et al. 2013).
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RNA sequencing analysis. Small RNAs (<150bp, including miRNAs), were purified by
gel electrophoresis. Paired-end sequencing (Illumina, 50bp) was performed on these small
RNAs (Expression Analysis Inc., Durham, NC). After clipping the adapter sequence, the small
RNA sequences matching mature mouse miRNAs (miRBase.org) were categorized and counted.
mRNAs with poly(A) tails were purified with oligo-dT magnetic beads and sequenced by the
Illumina system (paired-end, 50bp; Expression Analysis Inc.). RNA-seq reads were aligned to
the reference genome (UCSC mm9) and quantitated by the RSEM method (RNA-Seq by
Expectation Maximization) to provide accurate estimation of mapped transcripts (Li and Dewey
2011).
qRT-PCR. miRNAs were quantitated with predesigned Taqman probes for small RNA
controls and mature miRNAs (assay ID: snoRNA234, 001234; miR-155-5p, 002571; miR-5415p, 002562; miR-511-3p, 453069; miR-21(a)-3p, 002493; miR-298-5p, 002598; miR-18a-5p,
002422; miR-18b-5p, 002466; miR-138-5p, 002284; miR-144-3p, 002676; miR-134-5p, 001186;
miR-181c-3p, 464644; miR-146b-5p, 001097; miR-1934-5p, 121185) with the Taqman
MicroRNA Reverse Transcription kit and Taqman Universal Master Mix II (NO UNG) kit
(Applied Biosystems, Foster City, CA). snoRNA234 was used as an endogenous control to
standardize qRT-PCR results for miRNAs.
Statistical analysis. RNA-seq data were analyzed in the R/bioconductor platform
(bioconductor.org) with the edgeR package (Robinson et al. 2010). miRNA and mRNA counts
were analyzed with the generalized linear model (2*2 factorial design) to test for differentially
expressed miRNAs and mRNAs as a result of in utero SHS or a sex bias. The chromosome
location enrichment analysis was performed with Fisher’s exact test on 114 chromosome
locations, each consisting of a chromosome name (Chr.1-19,X,Y) and a major cytogenetic band
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designation (A,B,…, annotations accessible from UCSC Genome Bioinformatics). In addition,
the following R graphics packages: gclus, ggplot2 and Gviz, were used for visual presentation.
miRNA-mRNA pairing and Ingenuity Pathway Analysis (IPA). Target genes of
oncomirs were selected only if they were known targets according to at least 2 of the 4 target
predicting databases: DIANA-microT, miRanda, miRWalk and TargetScan (Betel et al. 2008;
Dweep et al. 2011; Lewis et al. 2003; Maragkakis et al. 2009). All anti-correlations between
miRNA and mRNA expression had to meet the following criteria: Pearson’s correlation
coefficient r≤-0.7, P-value<0.01; and at least 1.5 fold difference in the expression of target genes.
Information on 628 mouse tumor suppressor genes was found in the tumor suppressor genes
database, accessible from http://bioinfo.mc.vanderbilt.edu/TSGene/ (Zhao et al. 2013). The
miRNA-mRNA regulatory network was built in Ingenuity Pathway Designer and connections
between each gene and cancer were generated according to the Ingenuity Knowledge Base
(Ingenuity Systems, Redwood City, CA; www.ingenuity.com).

4.3 Results
Dysregulated miRNAs. Direct sequencing of small RNAs from lung samples of
BALB/c mice detected 504 miRNAs. The Venn diagram in Figure 4-1A shows the number of
miRNAs that were either dysregulated by in utero SHS exposures or biased by sex, as
determined for three levels of filtering thresholds. As shown in the top level of Figure 4-1A, the
most rigorous filtering threshold identified nine miRNAs with a significant smoke effect
(FDR<0.05). These nine miRNAs are miR-155-5p, miR-541-5p, miR-511-3p, miR-21-3p, miR298-5p, miR-341-3p, miR-501-5p, miR-18a-5p and miR-18b-5p.
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Figure 4–1. In utero SHS exposure dysregulates miRNA expression and high correlations were
found between elevated miRNA expression and increased inflammatory cytokine levels. miRNA
expression profiling (A) revealed more miRNAs significantly dysregulated by in utero SHS
exposure (B) than those biased by sex (C). The expression levels of miR-155, miR-21 and miR18a, confirmed by qRT-PCR, were significantly elevated in SO vs AO mice of either sex (D), and
were highly correlated with pro-asthmatic Th2 cytokine levels in BALF (E). The Venn diagram
(A) lists the numbers of dysregulated miRNAs according to different filtering thresholds (colors
of miRNAs: red, FDR<0.05; dark red, FDR<0.1 & P-value<0.003). For the color scheme in the
heat map, red/green=relative high/low expression. The qRT-PCR results (mean ± SEM) were
standardized to the expression of snoRNA234 (housekeeping small RNA) via the ΔΔCt method
and subtracted by 40 in order to set the baseline to 40 cycles, which is the detection limit of
quantitative PCR; each increment of one on the y-axis represents a 2-fold increase in expression
or 1-cycle difference in PCR results. Fold change values of “SOF versus AOF” and “SOM versus
AOM” are labeled and marked with asterisks to indicate statistical significance (P<0.05). The
units in the correlation plot for miRNA qRT-PCR results are 40-ΔΔCt and pg/ml for cytokine
levels. BALF: bronchoalveolar lavage fluid.
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All nine of these miRNAs were up-regulated by SHS exposure in utero. qRT-PCR
analyses were performed on seven of the nine miRNAs and up-regulation of all seven miRNAs
was confirmed, as shown in Figure 4-2.

Figure 4–2. The qRT-PCR results confirmed the up-regulation of in utero SHS-affected miRNAs.
Asterisks indicate significant differences between SHS-OVA and AIR-OVA in either sex (“SOF
versus AOF” or “SOM versus AOM”). Significant differences between SHS-OVA and AIR-OVA
groups were found for all miRNAs shown above except for miR-181c-3p (P<0.05, when females
and males were pooled).
In addition, two miRNAs, miR-1247-5p and miR-345-5p, exhibited a significant sex bias;
however, as indicated by Figure 4-3, qRT-PCR results did not show significant sex differences
in miRNA expression.
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Figure 4–3. The qRT-PCR results did not confirm sex differences in miRNA expression.
Significant differences between females and males were not found for either of the miRNAs listed
above.
The heat map in Figure 4-1 presents the expression patterns for the top 17 smokeaffected miRNAs and top 4 sex-associated miRNAs among all 4 groups across 16 samples (4
mice/group). These miRNAs meet the criteria of FDR<0.1 and P-value<0.003 (middle level of
Figure 4-1A) to allow more miRNAs to be plotted, while the most significantly up-regulated
miRNAs are retained. Correlation analysis performed on each sample revealed that the
expression levels of 3 miRNAs: miR-155-5p, miR-21-3p and miR-18a-5p (Figure 4-1D), were
very highly correlated with expression of the pro-asthmatic Th2 cytokines in BALF (Spearman’s
r≥0.6, P-value<0.001, Figure 4-1E). Although the up-regulation of these 3 miRNAs correlated
with asthma severity in the present study, further analysis revealed surprisingly that these
miRNAs (listed in Table 4-2) had been characterized previously as oncogenic miRNAs
(oncomirs).
Chromosome locations with increased transcriptional activity. Since the proasthmatic genes and oncomirs were both up-regulated by in utero SHS exposures and highlycorrelated, we investigated whether the increased transcription activity was enriched at any
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specific chromosome location. Degree of enrichment on each chromosome location for mRNA
only and miRNA only, indicated by –log10(P-value), is plotted in Figure 4-4A, together with a

Figure 4–4. Elevated miRNA and mRNA shared common chromosome locations. Differentially
expressed miRNAs and mRNAs in lungs of in utero SHS exposed BALB/c were found to be
enriched primarily at two mouse chromosome locations: Chr11C and Chr2E (A). For the most
prominent site, Chr11C, a genome axis along chromosome 11 was plotted with differentially
expressed miRNAs and mRNAs aligned accordingly (B). Symbols in red/green = significantly
up/down-regulated. A large number of differentially expressed transcripts were aligned to the C
region (81.8-90.2Mb, Mb: mega base pairs) of mouse chromosome 11.
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list showing the most significant chromosome locations, when miRNA and mRNA were both
included. As shown in Figure 4-4A, the 2 most significantly over-represented chromosome
locations are Chr11C (FDR=5.7E-5) and Chr2E (FDR=5.9E-4). The most prominent site, a
genome axis along chromosome 11, with all differentially expressed miRNAs and mRNAs
aligned accordingly, is presented in Figure 4-4B (symbols in red/green = significantly up/downregulated genes or miRNAs). A large number of differentially expressed transcripts, including
the pro-asthmatic Th2 cytokines: Il4, Il5 & Il13, the majority of asthma-associated chemokines,
and miR-21 & miR-144, have been aligned adjacent to the C region (81.8-90.2Mb, Mb: mega
base pairs) on mouse chromosome 11.
Tumor suppressor genes targeted by oncomirs. With complete transcriptome
screening results on miRNA and mRNA, we interrogated the potential target genes of oncomirs,
to test whether oncomirs with their transcriptional suppression capability can act to downregulate tumor suppressor genes. By cross-referencing 4 different miRNA target prediction
databases (DIANA-microT, miRanda, miRWalk and TargetScan) and 1 tumor suppressor gene
database (Zhao et al. 2013), we identified 16 tumor suppressor genes that i) are targeted by, and
ii) show anti-correlation with the oncomirs (Detailed pairing information is available in
Supplemental Material). These tumor suppressor genes include Apc, Apc2, Cav2, Crebl2, Grlf1,
Il17rd, Kif1b, Lats2, Mtus1, Notch1, Plce1, Reck, Thrb, Timp3, Wif1 and Zfhx3. The anticorrelation pattern between oncomirs and tumor suppressor genes was plotted in heat maps
(Figure 4-5A). The miRNA-mRNA regulatory network was built in IPA and the association of
the listed genes with cancer was independently confirmed by Ingenuity Knowledge Base (Figure
4-5B).
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Figure 4–5. Sixteen tumor suppressor genes were targeted by and showed anti-correlation with
activated oncomirs. By cross-referencing RNA-seq results for miRNAs and mRNAs, we found 16
tumor suppressor genes that were targeted by, and whose expression was inversely correlated with,
the 3 activated oncomirs, miR-155, miR-21 and miR-18a (A). The regulatory network built in
Ingenuity Pathway Analysis independently confirmed their association with cancer (B).
4.4 Discussion
This report examines the long-term effects of in utero exposure to SHS on modulation of
miRNA expression in adult mouse lungs, and addresses implications of this activity on adult
pulmonary diseases. The most significantly up-regulated miRNAs, miR-155, miR-21 and miR18a, also showed high correlation with pro-asthmatic Th2 cytokine levels in the BALF
originating from the same samples. In fact, other than miR-21, which has been reported to be
up-regulated in allergic airway inflammation and to set the balance between Th1 and Th2
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responses (Lu et al. 2011; Lu and Rothenberg 2013), miR-155 and miR-18a have not been
discussed in terms of allergic asthma, but rather as well-characterized oncomirs, whose
expression has been associated directly with increased lung cancer severity in human (Tang et al.
2013; Volinia et al. 2006; Yang et al. 2013). Whether miR-155 and miR-18a, play important
roles in both allergic asthma and lung cancer awaits further investigation. The disease
associations of these dysregulated miRNAs were tabulated in Table 4-2.
Table 4–2. In utero SHS exposure dysregulates miRNAs that are associated with lung cancer and
inflammation.
miRNAs
(mmu-)

RNA-seq
FDR & (Pvalue)

Associated lung diseases & disorders

qRT-PCR
Fold change

miR-155-5p

1.1E-08

Cancer (Tang et al. 2013; Yang et al.
2013) , inflammation (Tili et al. 2007)

♀: ↑2.4* ♂: ↑2.0*

miR-541-5p

2.8E-05

miR-511-3p

9.8E-04

Cancer (Zhang et al. 2012),
inflammation (Squadrito et al. 2012)

♀: ↑1.3 ♂: ↑1.7*

miR-21-3p

1.2E-03

Cancer (Tang et al. 2013; Yang et al.
2013), inflammation (Lu et al. 2009;
Moschos et al. 2007)

♀: ↑2.0 ♂: ↑2.4*

miR-298-5p

1.2E-03

miR-341-3p

1.9E-03

miR-501-5p

2.1E-03

miR-18a-5p

1.4E-02

miR-18b-5p

1.7E-02

miR-299-3p

0.05 (1.1E-03)

miR-138-5p

0.05 (1.2E-03)

miR-128-15p

0.08 (1.9E-03)

miR-144-3p

0.08 (2.1E-03)

♀: ↓1.3 ♂: ↑1.8*

♀: ↑2.0* ♂: ↑2.5*

Cancer (miR-17~92 cluster) (He et al.
2005; Hwang and Mendell 2007; Olive
et al. 2010)

♀: ↑1.8* ♂: ↑1.6*

Cancer (Seike et al. 2009)

♀: ↑1.7 ♂: ↑1.4

♀: ↑1.8 ♂: ↑3.6*

♀: ↑1.5 ♂: ↑2.3
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(Table 4–2 continued)
miRNAs
(mmu-)

RNA-seq
FDR & (Pvalue)

miR-155-3p

0.08 (2.4E-03)

miR-134-5p

0.08 (2.4E-03)

miR-30985p

0.09 (2.8E-03)

miR-181c3p

0.09 (2.9E-03)

Associated lung diseases & disorders

qRT-PCR
Fold change

Cancer (Chen et al. 2008)

♀: ↑1.3 ♂: ↑1.4

♀: ↓1.2 ♂: ↓1.1

qRT-PCR was performed on eleven miRNAs and significant up-regulation was found for seven of
them. *: statistical significance, P<0.05, ♀: SOF versus AOF, ♂: SOM versus AOM. N≥5 in each
group for qRT-PCR.
In contrast to the primarily down-regulated miRNA expression profiles identified in
adults that had been exposed to cigarette smoke (Izzotti et al. 2009; Schembri et al. 2009), the
up-regulation of these miRNAs in adult mice suggests that long-term effects of in utero SHS
exposure may include promotion of a pro-asthmatic and/or oncogenic environment in mice
challenged as adults with environmental irritants. This is in part consistent with our previous
observations that in utero SHS promotes a pro-asthmatic milieu in the adult lungs exposed to
OVA (Penn et al. 2007; Xiao et al. 2013).
To identify common chromosome locations where miRNAs and mRNAs might be coregulated by in utero SHS exposure, we screened all the chromosome locations on the mouse
genome, separated by major cytogenetic bands. Among these, Chr11C and Chr2E are most
significantly enriched for the differentially expressed miRNAs and mRNAs. As shown in Figure
4-4B, a number of asthma- and AHR-associated genes are located on mouse chromosome 11,
including Th2 cytokines (Il4, Il5 and Il13), pro-inflammatory chemokines (Ccl2, Ccl3), and
significantly up-regulated miRNAs (miR-21, miR-144). Both miR-21 and miR-144 (confirmed
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by qRT-PCR, Supplemental Material), are activated by diesel exhaust exposures (Yamamoto et
al. 2013). This suggests a miRNA-mRNA co-activation pattern at this chromosome location
upon environmental irritant challenge. The increased transcription activity induced by in utero
SHS exposure at these chromosome locations could be a result of epigenetic modifications,
including DNA methylation and specific histone modifications. In addition, the human
equivalents of the miRNAs and mRNAs located on mouse chromosome region Chr11C (81.890.2Mb) are located on the human chromosome Chr17. With the high degree of homology
between mouse and human genomes, further epigenomic study at these chromosome locations
should also help to elucidate the mechanisms by which environmental stressors influence early
stages in the development of a number of human diseases.
The activation of specific oncomirs raises a new question: are individuals who were
exposed to SHS in utero at heightened risk as adults for certain cancers? As a first step, we
examined the transcriptome responses that contribute to increased chances of developing cancer
and that are targeted by the oncomirs. Among the target genes of the 3 major oncomirs
identified in the present study, miR-155, miR-21 and miR-18a, we found 16 tumor suppressor
genes (12 of them also known to be associated with cancer by IPA), as listed in Table 4-3, that
were down-regulated in association with the up-regulated oncomirs. At least eight of the tumor
suppressor genes have been implicated directly in lung cancer. These eight genes include the
three Wnt/β-catenin signaling inhibitors: Apc, Apc2 & Wif1 (Bonner et al. 2004; Stewart 2014),
as well as five other lung cancer-associated genes: Cav2, Lats2, Notch1, Timp3 and Zfhx3
(Kettunen et al. 2004; Minamiya et al. 2012; Strazisar et al. 2009; Wang et al. 2011; Wu et al.
2012). These findings suggest that long-term consequences of in utero exposure to SHS include
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activation of oncogenic miRNAs in adult lungs, potentially resulting in decreased expression of
these tumor suppressor genes.
Table 4–3. According to multiple sources, sixteen tumor suppressor genes are predicted targets of
the 3 oncomirs, miR-155, miR-21, and miR-18a, and show anti-correlation with oncomir
expression.
miRNA

Gene

miR-155

Description

Lats2

DIANA
microT
1

miR
anda
1

miR
Walk
1

Target
Scan
1

Pearson
’s r
-0.82

Fold
Change
-1.76

large tumor suppressor 2

miR-155

Il17rd

1

1

1

1

-0.81

-1.52

interleukin 17 receptor D

miR-155

Crebl2

1

1

1

1

-0.8

-1.7

cAMP responsive element binding
protein-like 2

miR-155

Plce1

1

1

1

0

-0.84

-3.06

phospholipase C, epsilon 1

miR-155

Apc

1

1

0

1

-0.77

-1.77

adenomatosis polyposis coli

miR-155

Kif1b

0

1

1

0

-0.74

-1.61

kinesin family member 1B

miR-18a

Il17rd

0

1

1

1

-0.7

-1.52

interleukin 17 receptor D

miR-18a

Apc2

0

1

1

1

-0.77

-1.97

adenomatosis polyposis coli 2

miR-18a

Thrb

0

0

1

1

-0.72

-3.33

thyroid hormone receptor beta

miR-18a

Grlf1

0

1

1

0

-0.73

-1.58

glucocorticoid receptor DNA binding
factor 1

miR-18a

Mtus1

0

1

1

0

-0.74

-1.64

mitochondrial tumor suppressor 1

miR-18a

Notch1

0

1

1

0

-0.75

-1.87

Notch gene homolog 1 (Drosophila)

miR-18a

Zfhx3

0

1

1

0

-0.82

-1.67

zinc finger homeobox 3

miR-21

Cav2

1

1

1

1

-0.75

-1.73

caveolin 2

miR-21

Reck

1

1

1

0

-0.76

-1.84

reversion-inducing-cysteine-rich
protein with kazal motifs

miR-21

Timp3

1

1

1

1

-0.8

-1.77

tissue inhibitor of metalloproteinase 3

miR-21

Crebl2

1

1

1

1

-0.75

-1.7

cAMP responsive element binding
protein-like 2

miR-21

Wif1

1

1

1

0

-0.81

-2.49

Wnt inhibitory factor 1

miR-21

Il17rd

0

1

1

0

-0.73

-1.52

interleukin 17 receptor D

miR-21

Lats2

0

1

1

0

-0.71

-1.76

large tumor suppressor 2

Tumor suppressor gene database (Zhao et al. 2013); Multiple miRNA-mRNA pairing database
(Betel et al. 2008; Dweep et al. 2011; Lewis et al. 2003; Maragkakis et al. 2009).
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In addition, the regulatory effects of miRNAs may be largely exerted via translational
suppression, which would further decrease final protein products of tumor suppressor genes
(Baek et al. 2008; Sonkoly and Pivarcsi 2009). Whether in utero exposure to SHS promotes
oncogenesis in adult mouse lungs is currently under investigation in our laboratory.

4.5 Conclusion
In utero SHS exposure activates pro-asthmatic and oncogenic miRNAs genes in OVAchallenged adult female and male mice. The results support an environment-epigenome
interaction that results from in utero SHS exposure and suggests that miRNA expression in adult
mice, together with dysregulated gene expression, promotes a pro-asthmatic and oncogenic
milieu in adult mouse lungs exposed in utero to SHS. The enriched chromosome locations of
both mRNA and miRNA suggest that in utero SHS exposure may cause epigenetic
modifications at these locations that contribute to the increased transcription activity in adult
mice. These activated oncogenic miRNAs may promote cancer progression through inhibition of
tumor suppressor genes.
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CHAPTER 5.
CONCLUDING REMARKS
5.1 Benefits from New Technology Implemented in the Present Study
flexiVent - an improved and direct measurement of lung function. BUXCO’s wholebody plethysmography has been routinely implemented as the lung function testing method in
our laboratory over the past decade. As a noninvasive method, whole-body plethysmography has
two merits: i) it allows large-scale experiments with its decent throughput, i.e., runs
simultaneously on 8 mice per experimental session; ii) it also allows longitudinal studies that
can follow each individual animal through repeated measurements without losing or
traumatizing any of them during the procedure.
Over the years, the accuracy and reliability of measurements made by whole-body
plethysmography, particularly for one of the parameters named Penh (enhanced pause), have
been questioned by researchers (Alder et al. 2004). Although a high correlation exist between
Penh and lung resistance in BALB/c mice (DeLorme and Moss 2002; Hamelmann et al. 1997;
Singh et al. 2003) and that is the mouse strain used exclusively in our studies, the parameters
interpreted from whole-body plethysmography were largely determined by the spontaneous
breathing pattern of each animal, which could be influenced by factors unrelated to lung
resistance or AHR, including neural ventilator control or a loss of elastic recoil (Schwarze et al.
2005).
To overcome the short-comings of whole-body unrestrained plethysmography, there is a
new forced oscillation technique, and one of the successfully commercialized products using
this technique is flexiVent (SCIREQ Inc.; Montreal, QC, Canada). This method completely
bypasses the breathing pattern of each mouse by applying a standardized ventilation procedure
to each of the anesthetized and intubated mice. This method allows direct and more accurate
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assessment of the lung mechanics, including results for lung resistance and dynamic compliance,
which are regarded as the “gold standard” for precise and specific determinations of pulmonary
mechanics (Drazen et al. 1999; Irvin and Bates 2003; Glaab et al. 2007).
After completing the SHS-SHS and the SHS-OVA studies that are described in Chapter
2 & 3, we had the opportunity to use flexiVent for our lung function testing. In light of the
pronounced male response in the SHS-OVA study (Chapter 3; Xiao et al. 2013), we carried out
an experiment similar to the SHS-SHS study (Chapter 2; Xiao et al. 2012) but this time included
both male and female offspring. As shown in Figure 5-1, the flexiVent was able to distinguish
male mice exposed both in utero and as adults to SHS from the air-exposed controls, whereas
the plethysmography yielded very similar responses for all 4 groups and with differences largely
influenced by the sex of the mice. From a statistics perspective, the flexiVent results on ~8 mice
per group revealed significant differences (P<0.05, unpublished results) between SHS- and AIRexposed males, while plethysmography results on ~16 mice per group were not able to achieve
that.
In conclusion, the flexiVent is a better way of testing lung function, although wholebody plethysmography can still be a good addition, particularly for large scale screening and
longitudinal studies that require repeated measurements.
RNA-seq - a sensitive and accurate method for transcriptome screening. Technically,
RNA-seq technology innately provides better transcriptome assessment than microarray (Wang
et al. 2009), including i) having detailed sequencing information that allows us to examine new
transcripts or isoforms not previously identified by microarray, because RNA-seq does not rely
upon pre-designed microarray probes; and ii) having exact read counts for each sequence, which
provide improved accuracy at estimating gene expression differences.
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Figure 5–1. flexiVent (lower panels) distinguishes smoke-vs-air-exposed male mice (SSM vs
AAM) better than whole-body plethysmography (upper panels), which was primarily influenced
by sex. Two upper panels, indicating AHR, determined as Penh values and breathing frequency,
are assessed with whole-body plethysmography. Two lower panels, indicating lung resistance and
compliance, are measured by flexiVent. SSM, male mice doubly exposed, in utero and as adults,
to SHS; AAM, male mice without any smoke exposure.
Until recently, RNA-seq had not become a main-stream method for transcriptome
screening, in part probably because of the cost and lack of good technical/software support. Now
with more affordable prices, better technical support from companies, and a variety of updated
software packages available, we started using RNA-seq as a routine transcriptome screening
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method in 2013. Other than using RNA-seq for identification and quantification of miRNAs,
which was discussed in Chapter 4, we also took the opportunity to compare RNA-seq and
microarray results side by side on the same RNA samples.
Not surprisingly, RNA-seq exhibited improved sensitivity compared with microarray for
detecting up-regulated pro-asthmatic genes. Among 14090 unique genes with median counts
above zero that are annotated by the Reference Sequence (RefSeq) database, by RNA-seq we
identified 428 genes, most of which were up-regulated by in utero SHS exposure (data not
shown). Compared to microarray-based gene expression profiling results (Table 3-2; Figure 3-5;
Xiao et al. 2014), RNA-seq identified nearly 4 times more differentially expressed genes (428
versus 113).
More importantly, in the context of a mouse asthma model, the differentially expressed
genes that were not detected by microarray are key genes associated with asthma and AHR
(Figure 5-2), including major Th2 cytokines (Il4, Il5, Il10 and Il13) and C-C-motif chemokines
(Ccl3, Ccl11 and Ccl22). The differential expression of these 7 genes, plus Il33, was confirmed
by qRT-PCR, with more than 2-fold up-regulation in the SHS-OVA groups compared to AIR
controls (Table 5-1).
Since lung cytokines and chemokines generally are low abundance genes present in the
lung, we then compared the sensitivity between RNA-seq and microarray for detecting
differentially expressed genes, with regard to each gene’s relative abundance (Low, 25%;
Medium, 50%; High, 25%). As shown in Figure 5-2, the Pearson’s correlation coefficient is
highest (r≈0.6) for high abundance genes while lowest (r≈0.1, scattered near the vertical line
x=0) for low abundance genes.
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Figure 5–2. RNA-seq provided improved sensitivity for detecting differential expression among
pro-asthmatic genes (A). The low abundance genes primarily benefit from improved sensitivity of
RNA-seq, as shown for “SOF versus AOF” (B); “SOM versus AOM” (C). The arrows pointing
upwards crossing the 2-fold line in panel A (from fold change values estimated by microarray to
those via RNA-seq; colored by sex: ♀: red, “SOF versus AOF”; ♂: blue, “SOM versus
AOM”) indicated that differential expression of the genes listed was detected only by RNA-seq
but not by microarray. The low correlation (Pearson’s r≈0.1, between RNA-seq and microarray)
and more blue dots scattered near the vertical line (x=0) in panel B&C, indicated that the RNAseq had better sensitivity, particularly among low abundance genes (lowest 25%, in blue dots).
Thus, in the context of this mouse asthma model, these results demonstrate that while the
two transcriptome screening methods generate consistent results for high abundance genes,
RNA-seq has significantly improved sensitivity for detecting low abundance genes.
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Table 5–1. The qRT-PCR results confirmed the differential expression of eight asthma- and AHRassociated genes that are revealed by RNA-seq, but not by microarray.
Asthma and AHR
associated genes

qRT-PCR
fold change

Il4

♀: ↑1.8* ♂: ↑2.5*

Il5

♀: ↑1.3 ♂: ↑2.1*

Il10

♀: ↑2.7* ♂: ↑4.0*

Il13

♀: ↑2.4* ♂: ↑4.6*

Il33

♀: ↑1.4 ♂: ↑2.0*

Ccl3

♀: ↑1.4 ♂: ↑2.2*

Ccl11

♀: ↑1.4 ♂: ↑2.4*

Ccl22

♀: ↑2.7* ♂: ↑4.3*

Asterisks indicate significant differences between SHS-OVA and AIR-OVA in either sex
(P<0.05; “SOF versus AOF” or “SOM versus AOM”).
5.2 Research Summary
These experiments investigate the effects of second-hand smoke (SHS) exposure in utero
on adult lung responses to inhaled irritants, including SHS and OVA. Results demonstrate:
i) SHS exposures, in utero and as adults, act synergistically to aggravate adult lung
responses and promote a pro-fibrotic milieu in 15-weeks old adult mice that were exposed in
utero to SHS;
ii) The effects of in utero SHS exposure persist into 23-weeks old adult mice and further
aggravate asthmatic responses in lungs of OVA-challenged adult mouse; these responses
exhibited a sex bias, which is more pronounced in male offspring;
iii) In utero exposure to SHS also modulates the miRNA expression in lungs of 23weeks old OVA-challenged adult mice, showing overexpression of oncogenic miRNAs,
including miR-155-5p, miR-21-3p and miR-18a-5p, which could play a role in allergic asthma
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and/or promote an oncogenic milieu in adult mouse lungs via inhibition of miRNA-regulated
tumor suppressor genes.

5.3 Critical Thoughts for Future Studies
In addition to adopting new technology, including flexiVent and RNA-seq, to aid in the
future experiment, a few more steps could be taken to strengthen and further the subsequent
studies:
 Include both sexes to study sex-specific differences
As we discovered a more pronounced lung response in OVA-challenged adult male mice
exposed in utero to SHS, there are two clear questions that remain to be answered: i) whether
this trend continues with other adult irritants? ii) what is the mechanistic explanation underlying
this pronounced male response? To better answer these questions, it is advisable to include both
female and male offspring for any further study in order to reveal a larger picture and unveil the
answers to these questions.
 Expand inhaled irritant challenges to a variety of respiratory disease models
In addition to assessing AHR associated with inhaled irritants, we can expand our
horizon to a variety of respiratory disease models. Whether in utero SHS exposure accelerates
progression of other adult other respiratory disease, including fibrosis, emphysema, or lung
cancer, is of great interest.
 Explore diverse epigenetic regulatory mechanisms
As the first step into epigenetics, we have examined the expression of miRNAs. Further
exploration on diverse epigenetic regulatory mechanisms, including DNA methylation, histone
modifications, and various others, might better explain the sustained effect of in utero SHS
exposure in adult mice.
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